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ABSTRACT 
Central to the control of virtually all cellular activity is the regulation of 
gene expression. In eukaryotes, this regulation is greatly influenced by chromatin 
structure, which is itself regulated by numerous chromatin-remodeling 
complexes. These are typically large protein complexes with interchangeable 
subunits that allow for highly specialized functions in different cell types. 
Moreover, additional specificity can be gained through complexes formed from 
different subunit isoforms. Histone modifications also regulate chromatin by 
recruiting remodeling complexes to particular genomic regions. 
In this thesis we characterize MBD3C, an isoform of the Nucleosome 
Remodeling and Deacetylase (NuRD) complex subunit MBD3. MBD3 is essential 
for pluripotency and development, but MBD3C appears to be expressed only in 
embryonic stem cells (ESCs), and whether it forms a distinct NuRD complex, 
how its expression is regulated, and its precise function(s) remain unknown. We 
show that MBD3C forms a complete NuRD complex that functions redundantly 
with the other MBD3 isoforms in ESC gene regulation. Furthermore, MBD3C 
binds the SET/MLL complex subunit WDR5 through a conserved motif within its 
unique N-terminal region, and this interaction is necessary for the regulation of 
>2,000 ESC genes. Together, these findings indicate that ESCs can utilize 
isoforms of the same protein to achieve similar functions through diverse 
mechanisms. 
The second part of this thesis focuses on the role of the histone 
modification H3.3K56ac in pluripotency and differentiation. Although H3K56ac is 
well-studied in yeast, in mammalian cells it is far less abundant and its functions 
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are largely unknown. Our data indicate that the H3.3K56R mutant is largely 
normal for ESC maintenance and loss of pluripotency markers during 
differentiation, but H3.3K56ac is necessary for proper lineage commitment. 
Ongoing studies will characterize the H3.3K56Q phospho-mimetic mutant during 
differentiation, and examine H3.3K56ac function at lineage-specific genes. 
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CHAPTER I: INTRODUCTION 
 
The work in this dissertation focuses on two features of chromatin and the 
mechanisms by which they contribute to embryonic stem cell (ESC) biology. 
Much of ESC maintenance and function is centered on the ability to regulate 
gene expression, which in turn is directly linked to chromatin and the protein 
complexes that modify chromatin structure. Two defining properties of ESCs are 
self-renewal, the ability to infinitely and stably give rise to more ESCs, and 
pluripotency, the capacity to differentiate and form any of the cell types in the 
adult organism. Activation or repression of pluripotency-related genes instructs 
ESCs to continue to self renew or begin the differentiation process. The DNA 
encoding all genes is packaged with histone proteins into chromatin, and 
expression of a particular gene depends largely on accessibility of the gene’s 
DNA to RNA polymerase and the transcriptional machinery. Chapter II of this 
thesis examines an ESC-specific isoform of the MBD3 subunit of the 
Nucleosome Remodeling and Deacetylase (NuRD) complex, MBD3C. MBD3C is 
the smallest of three MBD3 isoforms present in ESCs, and was previously largely 
uncharacterized. My work establishes MBD3C as a member of a complete NuRD 
complex, which can functionally compensate for the larger Mbd3 isoforms. The 
second part of this thesis focuses on a histone modification, acetylated histone 
H3 lysine 56 (H3K56ac). This project originated from the observation that 
H3K56ac localizes to many of the same genomic regions (specifically gene 
promoters) as two of the ESC “master regulators” OCT4 and SOX2. Although the 
regulation, deposition, and functions of H3K56ac have been widely studied in 
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yeast, far less is known about H3K56ac in mammals. How H3K56ac might 
interact with pluripotency factors and its role in chromatin regulation during 
differentiation is still unknown. The study of H3K56ac is further complicated in 
mammalian systems by the presence of histone H3 variants, which could be 
differentially acetylated during a particular cell state or developmental stage. 
Chapter III describes ongoing experiments to elucidate the roles of H3K56ac in 
ESC pluripotency and differentiation. 
 
Embryonic stem cells 
 Embryonic stem cells were first isolated from mouse blastocysts in 1981 
(Evans and Kaufman, 1981; Martin, 1981). The two defining features of ESCs 
are self-renewal and pluripotency. Self-renewal is the ability to divide indefinitely 
while retaining the same undifferentiated state, while pluripotency is defined as 
the capacity to generate any somatic cell type in the organism. The blastocyst 
containing ESCs forms after a series of divisions of the zygote at around 
embryonic day 3 (E3). It is made up of the trophectoderm, which generates extra-
embryonic tissues, and the inner cell mass from which the pluripotent ESCs are 
derived. The ESCs are not totipotent, as they generally do not differentiate into 
the trophectoderm lineage, but are otherwise able to form all somatic cell types, 
including the cells of the germline.  
 The origins of ESC biology can be traced back to studies of embryonal 
carcinoma (EC) cells, a type of tumor cell also capable of self-renewal. Like 
ESCs, EC cells can give rise to multiple differentiated cell types in culture and 
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mice injected with single EC cells grew tumors containing multiple cell lineages 
(called teratocarcinomas). It was then shown that EC cells undergo differentiation 
in vitro via embryoid body (EB) formation similar to cells isolated from early 
mouse embryos (Martin and Evans, 1975). EBs are spherical aggregates of cells 
that can differentiate to form cells of each of the three germ layers (ectoderm, 
mesoderm, and endoderm), and EB assays in ESCs are thought to replicate 
developmental conditions in vivo and are widely used to date for differentiation 
studies. Furthermore, like EC cells the early mouse embryonic cells were 
pluripotent and could also give rise to teratocarcinomas when grafted elsewhere 
(reviewed in (Martello and Smith, 2014)). It was these cells, when expanded in 
culture without becoming cancerous that were labeled embryonic stem cells. 
Importantly, it was noted that ESCs had to be cultured on feeder cells to remain 
in the undifferentiated state. It was then shown that a cytokine secreted by the 
feeder cells, leukemia inhibitory factor (LIF) was the agent necessary to prevent 
ESC differentiation in culture (Smith et al., 1988; Williams et al., 1988). Through 
a series of phosphorylation events, LIF activates the transcription factor STAT3, 
which in turn upregulates pluripotency network transcription factors such as MYC 
and KLF4 (Cartwright et al., 2005; Hall et al., 2009; Matsuda et al., 1999; Niwa et 
al., 1998) 
Among ESC transcription factors, OCT3/4 (henceforth referred to as 
OCT4), SOX2, and NANOG are commonly known as “core” factors that maintain 
ESC pluripotency in conjunction with a large network of proteins that includes 
both transcription factors and chromatin modifying enzymes (Orkin and 
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Hochedlinger, 2011; Young, 2011). OCT4 is expressed in the early embryo, and 
expression is confined to the inner cell mass after blastocyst formation, with 
OCT4 null embryo cells differentiating largely along the trophectoderm lineage 
(Nichols et al., 1998; Niwa et al., 2000). When LIF is withdrawn from ESCs in 
culture, the expression of OCT4 quickly declines, and OCT4 is absent from 
differentiated cell types. Similar to Oct4 null ESCs, Sox2 null ESCs are not 
pluripotent and differentiate to trophectoderm-like cells (Masui et al., 2007). 
SOX2 acts as a cofactor alongside OCT4 at enhancers to regulate expression of 
various pluripotency genes (Nishimoto et al., 1999; Yuan et al., 1995) as well as 
the Oct4 and Sox2 expression themselves (Okumura-Nakanishi et al., 2005; 
Tomioka et al., 2002). A third factor essential for pluripotency, NANOG is also 
expressed only in undifferentiated cells. Overexpression of Nanog allows ESCs 
to self-renew and remain pluripotent in the absence of LIF (Chambers et al., 
2003; Mitsui et al., 2003), although Nanog appears to function independently of 
the STAT3 pathway (Chambers and Smith, 2004), and Nanog null ESCs are 
capable of continued self-renewal (Chambers et al., 2007). OCT4, SOX2, and 
NANOG cooperate in a positive feedback loop to maintain their own expression 
in pluripotent cells as well as the expression of known ESC regulators such as 
LIF signaling pathway or microRNA genes (Chen et al., 2008b; Marson et al., 
2008; Young, 2011). The core pluripotency network can be expanded to include 
chromatin regulatory complexes that can localize to the same gene regulatory 
elements as OCT4, SOX2 or NANOG and are thought to help promote the more 
“open” chromatin structure at these sites characteristic of ESCs (Orkin and 
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Hochedlinger, 2011). Mechanistically, it has recently been proposed that OCT4 
can act as a “pioneer” factor (Zaret and Carroll, 2011) through recruitment of the 
SWI/SNF complex to inaccessible regulatory sites. Nucleosome remodeling by 
SWI/SNF at said sites subsequently allows for binding and regulation by the 
remaining core transcription factors (King and Klose, 2017). Other chromatin 
regulatory complexes in both ATP-dependent remodeler and histone-modifying 
families have been shown to interact with OCT4, SOX2 or NANOG (Ang et al., 
2011; Liang et al., 2008), and the pluripotency network has further expanded to 
include long noncoding RNAs (lncRNAs) (Guttman et al., 2011).  
Differentiated or somatic cells can be reprogrammed to return to the 
pluripotent state by ectopic expression of the core pluripotency factors OCT4, 
SOX2, and KLF4 along with C-MYC (Takahashi and Yamanaka, 2006). These 
induced pluripotent stem cells (iPSCs) reactivate their endogenous pluripotency 
factors and their formation is further marked by methylation and deactivation of 
somatic genes, demethylation of other pluripotency genes, and the re-
establishment of activating histone marks and other hallmarks of ESC-like 
chromatin structure (reviewed in (Apostolou and Hochedlinger, 2013); and see 
below). Although the reprogramming process is lengthy and many cell types do 
not form iPSCs with high efficiency, recent studies have successfully identified 
barriers to reprogramming and optimized reprogramming conditions in various 
contexts (Bar-Nur et al., 2014; Rais et al., 2014; Vidal et al., 2014). As they are a 
renewable source of pluripotent cells, iPSCs have greatly facilitated the study of 
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regenerative biology and are a potentially useful tool for treatments of cancer and 
developmental diseases. 
 
Chromatin 
 Chromatin is the material within which the eukaryotic cell’s genetic 
information is packaged. It is composed primarily of DNA and histone proteins 
tightly packed into chromosomes in the nucleus of the cell. The nucleosome is 
the basic unit of chromatin, formed by 147 base pairs of DNA wrapped around an 
octamer of conserved histone proteins (two dimers of H2A and H2B and a 
tetramer of H3 and H4) (Kornberg, 1974; Luger et al., 1997). Although the 
primary function of chromatin is to organize and retain a cell’s entire DNA within 
the nucleus, the structure of chromatin is highly dynamic and closely regulated to 
accommodate cellular activities such as DNA replication, repair, transcription, 
and mitosis. Specifically, the densest regions of chromatin will be generally 
inaccessible to DNA replication, repair, or transcription factors while the 
chromatin at replication forks or sites containing active genes will be more 
loosely packed. Nucleosomes and the linker DNA connecting them can be seen 
in electron micrographs as “beads on a string”, and numerous genome-wide 
mapping studies have examined nucleosome occupancy and positioning within 
diverse eukaroyotes. Although the existence of higher order chromatin loops and 
interaction domains in vivo has been widely postulated, the details of higher 
order chromatin structure are only beginning to be known. The advent of 3C (and 
its variants 4C, 5C, HI-C), ChIA-PET, more recently Micro-C-based technologies 
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(Dekker et al., 2002; Dostie et al., 2006; Fullwood et al., 2009; Hsieh et al., 2015; 
Lieberman-Aiden et al., 2009; Zhao et al., 2006) have provided more insight into 
both short and long-range chromatin interactions. At the level of individual 
nucleosomes, variations in nucleosome architecture can manifest through post-
translational modifications of histones, enrichment or depletion of different 
histone variants, and nucleosome remodeling catalyzed by ATP-dependent 
protein complexes.  
 
ATP-dependent nucleosome remodelers 
 Rearrangements of nucleosomes along chromatin are often necessary to 
allow transcription and other protein factors access to key regulatory regions 
throughout the genome. This task is commonly performed by remodeling 
complexes, which can function by sliding nucleosomes along DNA, removing 
nucleosomes, or removing and replacing different histone variants within 
nucleosomes (Clapier and Cairns, 2009). Nucleosome remodelers are generally 
classified into four families (SWI/SNF, ISWI, INO80, and CHD); remodelers in all 
families possess a catalytic ATPase domain homologous to the DEAD/H family 
of helicases (Hargreaves and Crabtree, 2011). This ATPase was first identified in 
yeast in two separate genetic screens: one for genes that prevented mating type 
switching (swi mutants), and a screen for mutants inhibiting growth on sucrose 
(snf mutants) (Neigeborn and Carlson, 1984; Stern et al., 1984). The ATPase 
gene was identified in both screens and the ATPase thus became known as 
SWI2/SNF2. The families each harbor different classes of domains (e.g. 
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bromodomain on SWI/SNF, helicase/SANT domain on SWI/SNF and INO80, 
chromodomain on CHD, and SANT-SLIDE domain on ISWI), which aid in 
recognition of other chromatin proteins or binding modules generated by post-
translational modifications. 
 Chromatin remodelers play numerous roles in ESC pluripotency and 
development. In mammals chromatin remodelers are often large protein 
complexes with interchangeable subunits specific to particular cell lineages or 
developmental stages (reviewed in (Ho and Crabtree, 2010)). The ATPase 
BRG1, a member of the mammalian SWI/SNF complex BAF (BRG1-associated 
factor) is required for early embryonic development (Bultman et al., 2000) and is 
linked to the network of pluripotency transcription factors in ESCs (Young, 2011) 
where BRG1 depletion leads to loss of self-renewal and misregulation of 
pluripotency genes (Fazzio et al., 2008; Ho et al., 2009; Kidder et al., 2009). 
SWI/SNF complexes are also essential during the formation of different cell 
lineages in later developmental stages. For example, BRG1 is thought to bind 
enhancers to activate mesoderm and cardiomyocyte-specific genes in ESCs 
(Alexander et al., 2015) and mutants of BRG1 or its homolog Brahma in mice 
and zebrafish exhibit severe cardiac defects (reviewed in (Hota and Bruneau, 
2016)). Furthermore, tissue-specific BAF subunits are required for proliferation of 
neural progenitors (Lessard et al., 2007) and BRG1 is important in both neuronal 
and muscle cell differentiation (la Serna et al., 2001; Weider et al., 2012). ISWI 
complexes have similar roles as SWI/SNF in early embryonic development, with 
null mutants of the ISWI ATPase Snf2h exhibiting embryonic lethality (Stopka 
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and Skoultchi, 2003), and ISWI complexes are required for ectoderm, endoderm, 
and erythropoietic development and gene regulation (Landry et al., 2011; 2008; 
Yip et al., 2012). INO80 complexes also regulate ESC self-renewal, pluripotency, 
and differentiation. In yeast and mammals the INO80 subfamily members SWR1, 
p400, or SRCAP function primarily in deposition of the H2A.Z histone variant into 
nucleosomes (Htz1 in yeast), which is important for regulation of gene 
expression and differentiation (Creyghton et al., 2008; Krogan et al., 2003; 
Mizuguchi et al., 2004; Ruhl et al., 2006), while the INO80 subfamily removes 
H2A.Z from nucleosomes and replaces it with canonical H2A-H2B dimers 
(Papamichos-Chronakis et al., 2011). In ESCs INO80 and another SWR1-related 
complex, TIP60-p400 complex are both implicated in ESC-specific gene 
regulation and self-renewal. TIP60-p400 has both H2A.Z dimer exchange and 
histone acetyltransferase activity and represses developmental genes while 
INO80 activates pluripotency genes through RNA Polymerase II and Mediator 
recruitment (Fazzio et al., 2008; Wang et al., 2014). Finally, the functions of the 
CHD family in ESCs (specifically the CHD3 and CHD4 subfamily) are a major 
focus of this work and will be discussed in subsequent sections. CHD1 is 
required both during pre-implantation development to maintain euchromatin 
structure and pluripotency in ESCs (Gaspar-Maia et al., 2009) and later during 
blood cell development in the upregulation of hematopoietic-specific genes (Koh 
et al., 2015).The remaining members, CHD2 and CHD5-9 have diverse functions 
in multiple developmental stages (reviewed in Ho and Crabtree, 2010, and Hota 
and Bruneau, 2016). Together, it is apparent that ATP-dependent chromatin 
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remodelers have adapted to function in many different contexts by utilization of 
both unique domains that recognize particular chromatin landmarks and 
accessory subunits that are particular to certain cell or tissue types.  
 
Histone modifications 
 Alongside the information encoded in the sequence of DNA, histone 
modifications provide additional means for the regulation of chromatin. The first 
histone modifications identified were acetylation and methylation (ALLFREY et 
al., 1964) and the list of modifications has expanded to include ubiquitin, SUMO, 
phosphate, crotonyl, and other groups which are post-translationally added to 
histone residues. Advances in ChIP-Seq and mass spectrometry have allowed 
for the continuous identification and genome-wide mapping of further 
modifications to date (reviewed in (Kouzarides, 2007; Lawrence et al., 2016)).  
Histones can be simultaneously modified at many different residues, with some 
modifications present in multiple groups on the same amino acid (lysine and 
arginine methylation are probably the most well known examples), lending a 
great deal of potential complexity to studies of biological function. The ever 
increasing number of modifications and possible combinations of modifications 
led some researchers to propose the existence of a “histone code” (Strahl and 
Allis, 2000) which hypothesizes that distinct combinations of modifications are 
recognized by specific regulatory proteins which accordingly trigger a specific 
outcome. The validity of the histone code hypothesis has been strongly 
questioned (reviewed in (Rando, 2012)). Although the most well-studied 
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modifications are situated on the N-terminal histone tails, modifications have also 
been identified within the globular histone domains (Lawrence et al., 2016; 
Tessarz and Kouzarides, 2014). The functions of one such modification, 
acetylation of histone H3 lysine 56 in ESCs will be discussed in detail in Chapter 
III of this thesis (see also below). Two commonly known roles for histone 
modifications are 1) the regulation of higher order chromatin structure, and 2) the 
creation or elimination of binding sites for chromatin remodeling enzymes. An 
example of 1) is H4K16ac, which was shown to inhibit higher order chromatin 
folding and compaction (Shogren-Knaak et al., 2006). Countless instances of 2) 
exist; notable ones include H3K4 methylation and H3K9 methylation. H3K4 
methylation is catalyzed and bound by the trithorax group (Trxg) proteins 
(Wysocka et al., 2005) and has also been shown to inhibit binding of the NuRD 
complex (Zegerman et al., 2002). H3K9 methylation is associated with gene 
repression and can trigger heterochromatin formation at centromeres and other 
repetitive regions of the genome when bound by HP1 (Bannister et al., 2001; 
Lachner et al., 2001). Several families of chromatin modifiers have been 
identified that both catalyze and remove histone methylation, acetylation and 
other modifications, and the characteristic domains of chromatin remodelers 
(described in the previous section) have similarly evolved to recognize specific 
modifications (e.g. SWI/SNF family bromodomains bind acetylated histones, and 
CHD family chromodomains and PHD domains recognize methylated histones), 
implicating histone modifications in recruiting regulatory complexes to their target 
genes and in processes such as transcription, replication, and DNA repair 
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(Kouzarides, 2007; Lawrence et al., 2016).  While a particular modification can 
be associated with both active and repressed genes in different contexts, 
acetylation is generally correlated with active genes, as are some methyl marks 
such as promoter-proximal H3K4me3 and H3K36me3 in gene bodies. 
Deacetylation and other methyl marks such as H3K9me3 and H3K27me3 are 
correlated with silenced genes. It is important to note however, that while a 
particular modification is often mapped to a large subset of active or repressed 
genes, there is often little evidence that that modification directly activates or 
silences said genes.  
  Lysine 56 of histone H3 can be acetylated or methylated and associated 
with both transcriptional activation and repression (Hyland et al., 2005; Jack et 
al., 2013; Xu et al., 2005). H3K56ac is catalyzed by the RTT109 histone 
acetyltransferase and ASF1 chaperone in yeast (Driscoll et al., 2007; Han et al., 
2007; Schneider et al., 2006; Tsubota et al., 2007) and by p300/CBP and GCN5 
in Drosophila and mammals (Das et al., 2009; Tjeertes et al., 2009). Located in 
the globular histone fold domain of H3 (see Chapter III, Figure 3.1), H3K56 is 
thought to form water-mediated contacts between the nucleosome and the DNA 
(Luger et al., 1997; Masumoto et al., 2005); acetylation of H3K56 is believed to 
enhance nucleosomal unwrapping and “breathing”, allowing for increased DNA 
accessibility and remodeling by SWI/SNF complexes (Neumann et al., 2009). 
H3K56ac is required to recruit SWI/SNF to activate histone genes in vivo (Xu et 
al., 2005) and also for chromatin assembly both during DNA replication by the 
CAF-1 chaperone and in response to DNA damage (Chen et al., 2008a; Li et al., 
		
	
13	
2008; Masumoto et al., 2005). More recently in yeast, it has been shown that a 
K56 hyperacetylation mimic, H3K56Q promotes H2A-H2A.Z dimer exchange by 
the SWR-C chromatin remodeler, resulting in decreased promoter-proximal 
H2A.Z (Watanabe et al., 2013). H3K56ac and H2A.Z both mark promoter-
proximal nucleosomes with high turnover rate (Kaplan et al., 2008; Raisner et al., 
2005; Rufiange et al., 2007) and are thus associated with transcriptional 
activation. How these histone marks regulate gene expression remains largely 
undescribed, although loss of H3K56ac was recently shown to cause decrease in 
RNA polymerase II occupancy at sites of both coding and noncoding 
transcription (Rege et al., 2015). 
 H3K56ac has been detected in only very small amounts in mammalian 
cells (1% of histone H3 vs. ~30% in yeast) and its functions in mammals are still 
mostly unknown. In ESCs H3K56ac is thought to be important for both 
pluripotency and differentiation through its interactions with OCT4, SOX2, and 
NANOG at pluripotency genes, and through its enrichment at developmental 
regulators such as the HOX genes during differentiation (Tan et al., 2013; Xie et 
al., 2009). Deletion of Sirt6, a NAD-dependent deacetylase that targets H3K56, 
leads to de-repression of OCT4, SOX2, and NANOG during differentiation, and 
mis-expression of markers from all three germ layers (Etchegaray et al., 2015). 
 
Histone variants and chaperones  
Because the packaging of cellular DNA is essential in all cells, histones 
are among the most highly conserved proteins in eukaryotes. In mice and 
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humans the canonical histone genes are arranged in large, multicopy clusters 
distributed onto three chromosomes (Marzluff et al., 2002). The gene clusters are 
transcribed in a cell cycle-dependent manner during S phase, and histone 
transcripts possess a unique structure without introns and terminating in a stem-
loop structure in place of the typical poly A tail (Dominski and Marzluff, 1999) that 
allow for large quantities of histones to be synthesized when DNA is replicated. 
Although canonical histones make up the majority of the nucleosomes in the 
genome, a number of variants exist for every histone (H4 variants are only known 
to exist in a few lower eukaryotes) each with a unique gene sequence(s) and 
specific genomic localization(s). The histone variants are encoded by one or two 
genes separately from the histone clusters, and are expressed and deposited on 
chromatin throughout the cell cycle. While histone variants can be removed or 
exchanged from nucleosomes by ATP-dependent remodelers, histone 
chaperones function to assemble newly synthesized histones into nucleosomes. 
Chaperones can be specific to different histone variants; most notably the 
Chromatin Assembly Factor 1 (CAF-1) chaperone complex incorporates the core 
histone H3 variants H3.1 and H3.2 into chromatin following DNA replication, 
while the H3.3 variant is deposited by the HIRA, DAXX/ATRX, and p400 
complexes independently of replication (Drané et al., 2010; Goldberg et al., 2010; 
Lewis et al., 2010; Pradhan et al., 2016; Tagami et al., 2004). H3.3 differs from 
H3.1 and H3.2 by four or five amino acids (see Chapter III, Figure 3.1A) and the 
recognition of H3.3 by separate chaperones is specified by the changed amino 
acids in the histone fold domain (Ahmad and Henikoff, 2002). In addition to H3.3, 
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other H3 variants exist in mammals including the centromere- and testis-specific 
variants CENP-A and H3t (reviewed in (Szenker et al., 2011)).  
 H3.3 has traditionally been associated with actively transcribed genes and 
enhancers and is enriched for “active” histone modifications (Goldberg et al., 
2010; Hake et al., 2006; McKittrick et al., 2004; Wirbelauer et al., 2005). H3.3 
also co-localizes with H2A.Z on nucleosomes at many promoters and enhancers, 
such nucleosomes are believed to be less stable than nucleosomes containing 
canonical histones and thus more conducive to creating open chromatin structure 
and activating transcription (Chen et al., 2013a; Jin and Felsenfeld, 2007; Jin et 
al., 2009). Surprisingly, H3.3 is also associated with gene repression. It is 
enriched at heterochromatic regions and in ESCs is involved in silencing of 
endogenous retroviral elements (Elsässer et al., 2015; Goldberg et al., 2010). 
Furthermore, PRC2-mediated H3K27me3 is reduced in H3.3-depleted ESCs at 
developmental genes, resulting in increased expression of trophectoderm and 
other lineage markers (Banaszynski et al., 2013). 
 
Unique chromatin structure of embryonic stem cells 
 ESCs must precisely regulate the expression of different genes in order to 
retain both the capacity for self-renewal and the ability to differentiate. Depending 
on differentiation signals received, pluripotent ESCs are able to upregulate 
specific subsets of genes corresponding to any lineage. Thus, the structure and 
features of ESC chromatin largely differ from that of most somatic cell types. 
Most notably, ESCs exhibit a dynamic, “open” chromatin structure, which can be 
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visualized under the microscope by reduced staining for the heterochromatin 
markers HP1 and H3K9me3 as compared with differentiated cells (Meshorer and 
Misteli, 2006). In contrast to euchromatin, heterochromatin consists of highly 
condensed nucleosomes and its formation often results in gene silencing. As 
such, global transcription levels are elevated in ESCs (Efroni et al., 2008) and 
ESC knockdown of the chromatin remodeler Chd1 has been shown to trigger 
heterochromatin formation and reduced pluripotency (Gaspar-Maia et al., 2009). 
ESC chromatin is also enriched for “active” histone modifications such as 
H3K4me3 and H3K9ac. Another hallmark of pluripotent chromatin is a subset of 
gene promoters marked with both an active (H3K4me3) and a repressive 
(H3K27me3) histone modification by the Trxg and PRC2 complexes respectively. 
These “bivalent” genes are lowly expressed in undifferentiated cells or thought to 
be “poised” for activation in response to developmental signaling (Azuara et al., 
2006; Bernstein et al., 2006). During differentiation one of the marks is typically 
lost from the promoter while the other becomes enriched depending on whether 
the gene is expressed or silenced. Consistent with their poised state, bivalent 
genes tend to have low levels of DNA methylation, another repressive epigenetic 
mark, with he CpG islands of germline and Polycomb genes becoming 
increasingly methylated as ESCs differentiate and commit to specific lineages 
(Mohn et al., 2008).  
 
DNA methylation 
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 DNA methylation primarily occurs at the 5’ position of cytosine bases that 
immediately precede a guanine (CpG dinucleotides). Methylated cytosine (5mc) 
is conserved in many organisms ranging from fungal to plant and mammalian 
species and has broad functions in transcriptional control, genomic imprinting, 
and silencing of transposons (Goll and Bestor, 2005). Methylation in mammals is 
catalyzed by the DNA methyltransferases DNMT3A, DNMT3B, and DNMT1; an 
additional DNMT family member DNMT3L modulates methylation levels in ESCs 
and germ cells (Bourc'his et al., 2001; Neri et al., 2013). DNMT3A and 3B are “de 
novo” methyltransferases that establish methylation patterns during development 
and are required for embryonic viability in mouse (Okano et al., 1999), while 
DNMT1 largely methylates hemimethylated CpGs during DNA replication to 
maintain established methylation patterns. Although most mammalian CpGs are 
methylated, regions containing dense CpG clusters ranging from a few hundred 
to ~1000 base pairs are found at transcription start sites (TSSs) and are 
generally hypomethylated (Deaton and Bird, 2011). These CpG islands (CGIs) 
mark most “housekeeping” genes and tend to be enriched for H3K4me3 and 
other histone modifications associated with active transcription (Thomson et al., 
2010). In ESCs, pluripotency genes silenced upon differentiation become 
methylated while concurrently losing active and acquiring repressive histone 
modifications, thus enabling repressive heterochromatin formation at the gene 
promoters (reviewed in (Smith and Meissner, 2013)). Loss of DNA 
methyltransferases and methylation does not affect ESC self-renewal (Tsumura 
et al., 2006), although Dnmt3a and Dnmt3b double null cells are unable to 
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differentiate to most germ layers (Jackson et al., 2004). ESCs with decreased 
methylation resulting from Dnmt1 null mutations appear to upregulate 
trophectodermal markers (Ng et al., 2008) suggesting that DNA methylation 
functions to prevent otherwise pluripotent ESCs in the inner cell mass from 
forming extraembryonic tissues. Through its association with heterochromatin 
and repressive histone modifications, DNA methylation is linked to gene 
silencing. The primary mechanisms by which methylation could repress 
transcription are 1) 5mc at promoter regions could physically block transcription 
factors or RNA polymerase II from binding; 2) methylation could alter 
nucleosome occupancy or positioning at promoters and/or gene bodies to create 
repressive chromatin structure; or 3) methylation can recruit methyl-binding 
domain (MBD) proteins which themselves recruit repressive protein complexes. 
The MBD proteins with the exception of MBD3 bind methylated DNA (Klose and 
Bird, 2006) and are linked to transcriptional co-repressors (Jones et al., 1998; 
Kondo et al., 2005; Nan et al., 1998; Ng et al., 1999; Sarraf and Stancheva, 
2004; Zhang et al., 1999). Most of these co-repressors are histone deacetylases, 
although MBD1 associates with the H3K9 methylase SETDB1 to repress 
transcription during DNA replication (Sarraf and Stancheva, 2004). Functions of 
the MBD2 and MBD3 proteins will be described in more detail in the following 
sections.  
 DNA methylation can be lost either through failure of DNMT1 to restore 
methylation during replication or through active demethylation by TET family 
enzymes, which oxidize 5mc to 5-hydroxymethylcytosine (5hmc), 5-
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formylcytosine (5fc), and 5-carboxycytosine (5cac) (He et al., 2011; Ito et al., 
2010; 2011; Tahiliani et al., 2009). The oxidized intermediates are then converted 
back to unmodified cytosines by the base excision repair pathway (Bhutani et al., 
2011; Cortellino et al., 2011)). Although it is possible that 5hmc is merely an 
intermediate in DNA demethylation, it is very likely that 5hmc and the TET 
proteins have important cellular functions. The TET1 protein was identified as a 
fusion partner of the methyltransferase MLL in acute myeloid leukemia (Lorsbach 
et al., 2003; Ono et al., 2002) and TET2 is frequently mutated in leukemia 
patients (Cimmino et al., 2011; Wu and Zhang, 2011). In ESCs, TET1 and TET2 
KD ESCs have self-renewal defects and similarly to Dnmt1 mutants can 
differentiate into trophectoderm (Ito et al., 2010; Koh et al., 2011)), although Tet1 
null mice are still viable (Dawlaty et al., 2011). Although current evidence 
indicates that TET1 and TET2 are regulated by OCT4 and the core pluripotency 
factors (Koh et al., 2011; Wu et al., 2013), and our lab has identified 5hmc as a 
possible recruitment module for MBD3 and the NuRD co-repressor complex 
(Yildirim et al., 2011) see below) future studies are necessary to more precisely 
determine the roles of TET proteins and 5hmc in ESCs and development.  
 
The Nucleosome Remodeling and Deacetylase Complex 
 
 The NuRD complex (originally known as the Mi-2 complex) was isolated 
and characterized by four separate groups in 1998 (Tong et al., 1998; Wade et 
al., 1998; Xue et al., 1998; Zhang et al., 1998). The first three groups sought to 
understand how chromatin-remodeling complexes might regulate transcription 
and to that end were biochemically characterizing HeLa cell histone deacetylase 
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or SWI2/SNF2 remodeler complexes. The remaining group isolated the related 
deacetylase activity from Xenopus egg extracts following an observation that 
deacetylation was important for normal Xenopus development. Each of the 
studies described a complex containing parallel ATP-dependent nucleosome 
remodeling activity and histone modification (deacetylase) activity, a property 
unique to NuRD. The complex is highly conserved in metazoans and contains at 
least one subunit from each of five major protein families (Figure 1.1). Several 
groups have reported additional proteins that co-purify with NuRD in different 
tissue and cell types (reviewed in (McDonel et al., 2009)). Because deacetylation 
is traditionally associated with transcriptional repression, NuRD is primarily 
known as a repressive complex, and the ATP-dependent remodeling activity is 
thought to block RNA polymerase II and transcription factors at promoters by 
increasing nucleosome occupancy (Denslow and Wade, 2007; Hainer and 
Fazzio, 2015; Yildirim et al., 2011). In addition to transcriptional control, NuRD 
activity is also associated with higher order chromatin assembly, maintenance of 
genome stability, hematopoietic stem cell differentiation, various human cancers, 
and aging (Lai and Wade, 2011; Pegoraro et al., 2009; Yoshida et al., 2008).  
 
Overview of NuRD subunits 
 In support of the idea that multiple different NuRD complexes and sub-
complexes are adapted for highly specific functions, the NuRD complex is highly 
modular, with many subunits interchangeable, mutually exclusive, or present only 
in certain cell types. The enzymatic subunits of the canonical NuRD complex are 
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an ATP-dependent remodeler (CHD3 or CHD4, also known as MI2-α and MI2-β), 
and two histone deacetylases (HDAC1 and HDAC2). Other subunits are the 
metastasis-associated proteins MTA1, MTA2, or MTA3, WD40 repeat proteins 
RBBP4 and RBBP7 (also known as RBAP48 and RBAP46), the zinc finger 
proteins p66α and p66β (also known as GATAD2A and GATAD2b), and the 
methyl binding domain proteins MBD2 or MBD3. The exact stoichiometries of 
each subunit are still unknown, but a recent study using applied mass 
spectrometry analysis suggests that there is a single ATP remodeling subunit 
(either CHD3 or CHD4) and a single deacetylase (HDAC1 or HDAC2) (Smits et 
al., 2013). The study also proposes three subunits of MTA1, 2, or 3; six subunits 
of RBBP4 and/or RBBP7; one MBD3; two subunits of p66α or p66β (Figure 1.1), 
and two of an additional DOC1 subunit. Using structural studies, Schwabe and 
colleagues propose an alternative stoichiometry where an MTA homodimer binds 
two HDAC and four RBBP4/7 subunits (Millard et al., 2016; 2013).  
Several subunits have been identified as members of related chromatin 
modifying complexes and sub-complexes such as CoREST, NODE, and MeCP1 
(Liang et al., 2008; Ng et al., 1999; You et al., 2001), and NuRD’s deacetylase 
activity can function independently of the chromatin remodeling subunit in vitro 
(Low et al., 2016), suggesting that NuRD’s enzymatic activites can act either 
separately, together within the complex, and/or in conjunction with other 
chromatin remodelers. Numerous peripheral subunits are present in functionally 
specialized NuRD complexes. One such example is LSD1, an H3K4 and H3K9 
demethylase which is co-enriched with NuRD at enhancers in ESCs (Whyte et 
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al., 2012) and binds the MTA subunits of NuRD in breast cancer cells (Wang et 
al., 2009b). LSD1 and NuRD-mediated enhancer activity is essential for proper 
ESC differentiation, while Wang et al. propose that LSD1 inhibits breast cancer 
metastasis. A second NuRD-interacting protein is FOG1, which interacts with 
NuRD in erythroid progenitors and is important for hematopoietic differentiation 
(Gao et al., 2010; Hong et al., 2005). A third such example is BCL6, a 
transcriptional repressor that functions with the NuRD MTA3 subunit to control B 
lymphocyte cell fate (Fujita et al., 2004). The canonical NuRD subunits are 
described below, with emphasis placed on their function in ESCs.  
 The CHD3 and CHD4 proteins are ATP-dependent nucleosome 
remodeling subunits. Also known as MI2-α and MI2-β, they were first identified in 
dermatomyositis patients as autoantigens (Seelig et al., 1995). Like all CHD 
family members, CHD3 and 4 contain the SWI/SNF ATPase/helicase domain, 
and two tandem-terminal chromodomains, which can bind methylated H3 or DNA 
and are required for nucleosome remodeling (Clapier and Cairns, 2009). In 
addition to their chromodomains and ATPase domain, CHD3 and 4 also each 
contain two plant homeodomain (PHD) fingers, which also bind methylated H3 
tails (Musselman et al., 2012). In ESCs, CHD4 KD leads to loss of self-renewal 
capability, decreased proliferation, and increased embryoid body (EB) 
differentiation as measured by downregulation of the pluripotency markers OCT4 
and TBX3 and upregulation of germ layer marker genes (Zhao et al., 2017). 
Recently, a third CHD family member, CHD5 has also been co-purified with the 
canonical NuRD subunits (Kolla et al., 2015; Nitarska et al., 2016; Quan et al., 
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2014). CHD5 is required along with CHD3 and CHD4 at distinct stages of 
neuronal differentiation and brain development, and the CHD subunits form 
mutually exclusive NuRD complexes that specifically regulate genes during the 
different developmental stages (Egan et al., 2013; Nitarska et al., 2016). CHD5 is 
not highly expressed in most tissue types outside of the brain and the testis, 
where it is also necessary for spermatogenesis (Li et al., 2014; Zhuang et al., 
2014). 
 The HDAC1 and HDAC2 subunits are Class I lysine deacetylases and 
homologs of the yeast RPD3 deacetylase. In ESCs, HDAC1 binds promoters of 
pluripotency genes and cells treated with the HDAC inhibitor trichostatin A (TSA) 
exhibited a flattened morphology consistent with differentiation (Kidder and 
Palmer, 2012). Interestingly, the expression of a subset of pluripotency genes 
decreased after TSA treatment, suggesting that HDAC1 could be linked to gene 
activation as well as repression. Other studies have provided additional evidence 
for a role for HDACs in transcriptional activation (Zupkovitz et al., 2006).  
 The role of the MTA1, MTA2, and MTA3 subunits within the NuRD 
complex and in ESCs is largely unknown. MTA1 and 2 have been widely 
characterized in cancer metastases, particularly in breast cancer where high 
MTA1 expression levels have been linked to tumorigenesis (reviewed in Lai and 
Wade, 2011).  Each MTA family member contains four conserved domains: 
bromo-adjacent homology (BAH), SANT, EGL-27 and MTA1 homology (ELM), 
and GATA zinc finger. The specific function(s) of each domain are also unknown, 
but are hypothesized to be involved in recognition and binding to other NuRD 
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subunits and mediating interactions between the complex and other proteins. In 
support of this hypothesis, a study by Kumar and colleagues reported that 
methylated MTA1 is involved in NuRD assembly and is also required for CHD4 
nucleosome remodeling in vitro (Nair et al., 2013). 
 The RBBP4 and RBBP7 subunits (also named RBAP48 and 46 for their 
respective molecular weights) are members of the WD40 repeat protein family. 
WD40 proteins exhibit a characteristic seven-bladed β-sheet propeller structure 
with each blade approximately 40 amino acids in length and flanked by N- and C-
terminal helical tails. RBBP4 and RBBP7 were first identified and named for their 
interaction with the retinoblastoma tumor suppressor protein and later shown to 
bind histones. One or both of RBBP4 or RBBP7 have been co-purified with 
several additional complexes such as the Polycomb Repressive Complex 2 
(PRC2), and Chromatin Assembly Factor 1 (CAF1), and Nucleosome 
Remodeling Factor (NURF) complexes, and the RBBP proteins are thought to be 
important both as structural subunits and in recruiting chromatin modifiers to their 
genomic targets through their histone binding properties.  
The MBD3 and MBD2 subunits are mutually exclusive within the NuRD 
complex (Le Guezennec et al., 2006). As the biology of MBD3/NuRD is central to 
the work presented in Chapter II of this thesis, the origins of MBD3 and its known 
functions in ESCs will be discussed in more detail in the following section. 
Identified alongside MBD3 and MBD4, MBD2 contains a domain (the MBD), 
which binds methylated CpG dinucleotides on DNA (Hendrich and Bird, 1998) 
and a C-terminal transcription repression domain. As such, MBD2 is thought to 
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function in recruiting NuRD to its target genes as a “reader” of methylated DNA. 
MBD3 is the only MBD protein that does not bind methylated DNA, and contains 
a glutamate repeat domain of unknown function at its C-terminus. Despite always 
associating with separate NuRD complexes, MBD2 and MBD3 localize 
interdependently to many of the same genomic regions (Günther et al., 2013; 
Hainer et al., 2016). However, Mbd2 and Mbd3 exhibit very different phenotypes 
in vivo- Mbd3 null mice are embryonic lethal at 8.5 d.p.c., while Mbd2-null mice 
survive to adulthood, though Mbd2 null females exhibited abnormalities in 
maternal behavior resulting in smaller offspring (Hendrich et al., 2001). Both 
MBD2 and MBD3 bind the p66α and p66β subunits (Brackertz et al., 2002). Also 
known as GATAD2a and GATAD2b, these proteins each contain a conserved 
GATA zinc finger domain that can bind histone tails, although binding appears to 
be inhibited if histone tails are acetylated (Brackertz et al., 2006). p66α and p66β 
also interact with the HDAC1 and RBBP7 subunits in a sumolyation-dependent 
manner, indicating that p66α and p66β play both structural and recruitment roles 
within NuRD (Gong et al., 2006). 
It is clear from the above overview that there is still much to be discovered 
about the biology of the NuRD complex. While there is a general consensus on 
the identities of the canonical subunits, the list of peripheral proteins interacting 
with NuRD continues to expand, one of which is a main focus of this thesis. 
Further studies will be necessary to determine how each subunit functions both 
within and outside the context of a NuRD complex or subcomplex, and whether 
these functions are universal or specific to particular cell or tissue types. It is well 
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established that NuRD impacts both chromatin structure and transcription in 
many cell types, and much present work aims to elucidate how NuRD is recruited 
to different target genes, the precise mechanism(s) by which the complex effects 
gene repression, and how crosstalk between NuRD and other chromatin 
regulatory complexes affects these processes. The following chapter will focus 
on a single subunit, MBD3 and its role in NuRD activity in ESCs.  
 
Functions of MBD3/NuRD in embryonic stem cells and development 
The first discovered methyl-DNA binding proteins were MECP1 and 
MECP2 (Lewis et al., 1992; Meehan et al., 1989). The biology of MECP2 became 
of particular interest when mutations in the MeCP2 gene were found to cause 
Rett Syndrome, an X-linked neurodevelopmental disease that is lethal in males 
(Amir et al., 1999). Hendrich, Bird, and colleagues subsequently identified Mbd3 
and its counterparts Mbd1, 2, and 4 while searching an EST (expressed 
sequence tag) database for additional methyl binding domain proteins (Cross et 
al., 1997; Hendrich and Bird, 1998). Two MBD3 isoforms, MBD3A and MBD3B 
were originally identified with a third, MBD3C, described later in mouse (Hendrich 
and Bird, 1998; Kaji et al., 2006). The MBD is truncated in MBD3B at amino 
acids 5-36 and is completely absent in MBD3C (see Chapter II).  
Unlike MECP2 and the other Mbd family members, MBD3 does not bind 
methylated DNA (Hendrich and Bird, 1998; Zhang et al., 1999), despite its 
sequence being ~70% similar to that of MBD2. Analysis of the MBD3A MBD 
reveals that two amino acids present in mice and humans, His-30 and Phe-34, 
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are replaced by Lys and Tyr respectively in most non-mammalian species 
(Hendrich and Tweedie, 2003). Although MBD3’s MBD does not bind 
methylcytosine (5mc), data have shown that mutating His-30 and Phe-34 back to 
Lys and Tyr restores the ability of MBD3 to bind 5mc (Saito and Ishikawa, 2002). 
Mbd3 appears to bind more selectively to hydroxymethylated DNA and 
unmethylated DNA than methylated DNA in vitro (Mellén et al., 2012; Yildirim et 
al., 2011) and MBD3 and 5’hydroxymethylcytosine (5hmc) map to overlapping 
regions of the genome in ESCs (Wu et al., 2011; Yildirim et al., 2011). Cytosine 
bases methylated at the 5’ position (5mc) are converted to 5hmc by the 
hydroxylase TET1 (Tahiliani et al., 2009) and Tet1 KD ESCs exhibit phenotypes 
similar to Mbd3 KD ESCs (Ito et al., 2010; Koh et al., 2011). Although our lab’s in 
vitro binding data has been contested by data from other groups (Hashimoto et 
al., 2012; Spruijt et al., 2013), we observed that genome-wide MBD3 localization 
is lost in Tet1 KD cells and Tet1 catalytic-inactive mutant cells (Hainer et al., 
2016; Yildirim et al., 2011), indicating that TET1 and 5hmc are important for 
MBD3/NuRD to bind its target genes in ESCs.  
In an RNAi screen to identify chromatin regulators important for murine 
ESC self-renewal, our lab identified MBD3 as important for maintenance of the 
ESC state (Fazzio et al., 2008). It was further observed that nucleosome 
occupancy is decreased and RNA Polymerase II recruitment is increased at 
MBD3 target genes in Mbd3 KD ESCs (Yildirim et al., 2011), indicating that 
MBD3 is a transcriptional repressor. Additionally, Mbd3 null mice are nonviable 
(Hendrich et al., 2001) and ESCs derived from Mbd3 null mouse embryos are 
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capable of self-renewal in culture in the absence of leukemia inhibitory factor 
(LIF) and are compromised in pluripotency, with differentiation skewed toward 
the trophectoderm lineage (Kaji et al., 2006; 2007; Zhu et al., 2009) MBD3 was 
subsequently shown to be important for differentiation and development through 
silencing of a subset of pluripotency genes (Zfp42, Tbx3, Klf4, and Klf5) and the 
expression of these genes persists after removal of LIF in Mbd3 KD ESCs 
(Reynolds et al., 2012). From this study, it was hypothesized that MBD3/NuRD 
could function to oppose the LIF/STAT3 pathway, which activates the same 
subset of pluripotency genes. In support of this hypothesis, our lab found that 
MBD3 interacts with and localizes to several hundred of the same genes as the 
esBAF catalytic subunit BRG1. BRG1 is required for STAT3 to localize to many 
of its target genes (Ho et al., 2011) and MBD3 and BRG1 were observed to 
oppositely regulate expression of their shared target genes (Yildirim et al., 2011).  
Furthermore, MBD3 is essential for NuRD complex assembly (Kaji et al., 2006) 
and NuRD target genes exhibit increased H3K27 acetylation and decreased 
H3K27 trimethlyation in Mbd3 null ESCs (Reynolds et al., 2011), suggesting that 
MBD3 regulates pluripotency genes through NuRD-mediated deacetylation and 
recruitment of the H3K27 methyltransferase Polycomb Repressive Complex 2 
(PRC2). Taken together, the abovementioned studies point towards a model 
where MBD3/NuRD works to maintain equilibrium in ESC target gene expression 
alongside other chromatin modifiers which in turn allows ESCs to flexibly 
coordinate the self-renewal or differentiation processes (Hu and Wade, 2012). 
Although there are some discrepancies in ChIP binding profiles as to exactly 
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where MBD3/NuRD maps in the ESC genome it appears that like PRC2, 
MBD3/NuRD is a largely repressive complex and functions in opposition to gene 
activating complexes like esBAF and STAT3.  
The role of MBD3/NuRD in iPSC reprogramming is controversial. Two 
groups provided initial evidence that Mbd3 deletion greatly enhances 
reprogramming efficiency (Luo et al., 2013; Rais et al., 2014) with Rais et al. 
reporting successful reprogramming of nearly 100% of induced cells to 
pluripotency. This result was subsequently challenged by work from Hendrich, 
Silva, and colleagues who reported that Mbd3 is required for both initial and later 
stage reprogramming of neural stem cells and as well as reprogramming of 
epiblast stem cells to naïve pluripotency (Santos et al., 2014). To date the 
discrepancies between these data remain largely unresolved (Bertone et al., 
2015; Zviran et al., 2015), although differing reprogramming reagents/contexts 
and/or experimental conditions are likely contributors to the contradictory results. 
 
Functions of WDR5 in embryonic stem cells 
WDR5 (WD repeat protein 5) is conserved from yeast to humans and is a 
member of several transcriptional co-activator complexes (Cai et al., 2010; Dou 
et al., 2006; 2005; Ruthenburg et al., 2006). It is most commonly known as a 
subunit of SET/MLL (SuVar3-9, Enhancer of zeste and Trithorax/Mixed Lineage 
Leukemia), a histone methyltransferase complex homologous to the yeast 
COMPASS complex. The SET/MLL proteins are also homologs of the Drosophila 
trithorax group (Trxg) proteins, which were first identified as positive regulators of 
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the Drosophila Hox gene cluster, and thought to function to counteract the 
Polycomb Group (Pcg) negative regulator proteins (reviewed in (Schuettengruber 
et al., 2011)). COMPASS was subsequently purified from yeast as the first H3K4 
methylase (Miller et al., 2001; Roguev et al., 2001). H3K4 methylation is 
catalyzed by the SET1 subunit (encoded by the MLL gene in humans and mice) 
and the complex can catalyze all forms of H3K4 methylation (H3K4me1, 2, and 
3). WDR5 and the other complex core subunits ASH2L and RBBP5 are essential 
for this catalytic activity in yeast and mammals. WDR5 binds di- and tri-
methylated H3K4 and has been shown to activate transcription in reporter gene 
assays and to be required for HOX gene expression maintenance (Wysocka et 
al., 2005). However, although the H3K4me3 mark is widely associated with 
transcriptional activation as it localizes to the promoters of many active genes 
(Bernstein et al., 2002; Santos-Rosa et al., 2002), it does not appear to itself 
directly activate these genes.  
In ESCs, WDR5 is required for proper self-renewal, and its expression 
decreases along with H3K4me3 levels during differentiation (Ang et al., 2011). 
Consistent with these observations, Ang et al. further showed that Wdr5 KD 
MEFs did not reprogram to iPSCs as efficiently as wildtype, and that WDR5 both 
physically interacts with and binds to overlapping genomic regions as OCT4, 
likely co-regulating genes important for ESC maintenance. WDR5’s activity within 
the SET/MLL complex is of particular importance in maintaining H3K4me3 at the 
aforementioned “bivalent” genes in ESCs. Another mechanism by which WDR5 
maintains ESC chromatin state is through histone acetylation. WDR5 was also 
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purified as a member of MOF (Male absent On First), a protein complex with both 
H4K16 acetyltransferase and H3K4 methyltransferase activity (Dou et al., 2005). 
Like H3K4me3, H4K16ac is associated with transcriptional activation, and Mof 
null ESCs exhibit similar self-renewal and pluripotency defects as Wdr5 KD 
ESCs (Li et al., 2012). Additionally, there are two types of MOF-containing 
complexes in Drosophila and mammals, the male-specific lethal (MSL) and non-
specific lethal (NSL) and WDR5 is also a member of both (Zhao et al., 2013). 
MSL and NSL bind different genomic regions and have separate functions in 
ESCs (Chelmicki et al., 2014; Ravens et al., 2014), and the exact function(s) of 
WDR5 in each of these MOF complexes is still unknown.  
An additional mechanism for WDR5 function in ESCs is through 
interaction with lncRNAs. LncRNAs are >200bp RNAs that are typically 
processed (contain a 5’cap and polyA tail) and are not usually translated 
(Guttman et al., 2013; Wang and Chang, 2011). Following up on studies 
characterizing interactions between WDR5 and lncRNAs (Gomez et al., 2013; 
Wang et al., 2011), Howard Chang and colleagues identified ~1000 RNAs 
binding to WDR5 in ESCs using a variant of RNA immunoprecipitation, 
RNA:protein immunoprecipitation in tandem (RIPiT-Seq, (Yang et al., 2014)). 
Through additional analysis of lncRNA binding site mutants, Yang et al. showed 
that lncRNA binding to WDR5 was required for stable H3K4 trimethylation and 
proper expression of pluripotency genes in ESCs. Additionally, WDR5 protein 
levels were reduced in the lncRNA binding site mutants, suggesting a model 
where lncRNA binding would stabilize WDR5 levels, thus allowing SET/MLL 
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complex assembly and activity at target genes. Taken together, these studies 
establish that WDR5 can regulate ESC chromatin and gene expression through 
multiple complexes and mechanisms, and that Wdr5 is likely essential for proper 
ESC function.
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                    A 
																																		 																																						B                                                     
														 		 					 	 Figure 1.1: The NuRD complex 
   
(A) Schematic of the NuRD complex showing predicted subunit stoichiometries  
(Smits et al., 2013). (B) Schematic of canonical NuRD subunit families and their  
known domains. See text for details.
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CHAPTER II: AN ES CELL-SPECIFIC NURD COMPLEX FUNCTIONS 
THROUGH INTERACTION WITH WDR5 
 
PREFACE 
 
Chapter II is derived from an article of the same name published in Stem Cell 
Reports under a Creative Commons License: 
 
Ee, L.S., McCannell, K.N., Tang, Y., Fernandes, N., Hardy, W.R., Green, M.R., 
Chu, F., and Fazzio, T.G. (2017). Stem Cell Reports 8, 1488-1496. 
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experiments in Figure 2.7A. 
 
Mass spectrometry experiments were performed in collaboration with Feixia Chu, 
Yang Tang, and Nancy Fernandes (Figure 2.2D; Tables 2.1 and 2.2). 
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reprogramming reagents. Rod Hardy assisted with reprogramming experiments 
(Figure 2.4C-E). 
 
All other experiments were performed and analyzed by Ly-sha Ee and designed 
by Ly-sha Ee and Tom Fazzio. Ly-sha Ee and Tom Fazzio wrote the manuscript 
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ABSTRACT 
The Nucleosome Remodeling and Deacetylase (NuRD) complex is a 
chromatin regulatory complex that functions as a transcriptional co-repressor in 
metazoans. The NuRD subunit MBD3 is essential for targeting and assembly of a 
functional NuRD complex as well as embryonic stem cell (ESC) pluripotency. 
Three MBD3 isoforms (MBD3A, MBD3B, and MBD3C) are expressed in mouse. 
Here, we find that the MBD3C isoform contains a unique 50–amino acid N-
terminal region that is necessary for MBD3C to specifically interact with the 
histone H3 binding protein WDR5. Domain analyses of WDR5 reveal that the H3 
binding pocket is required for interaction with MBD3C. We find that while Mbd3c 
KO ESCs differentiate normally, MBD3C is redundant with the MBD3A and 
MBD3B isoforms in regulation of gene expression, with the unique MBD3C N-
terminus required for this redundancy. Together, our data characterize a unique 
NuRD complex variant that functions specifically in ESCs. 
 
INTRODUCTION 
Embryonic stem cells (ESCs) are characterized by two unique properties: 
1) self-renewal, the ability to indefinitely produce more stem cells and 2) 
pluripotency, the ability to differentiate into any cell type. To maintain their cellular 
identity ESCs utilize a network of core transcription factors, which bind and 
regulate pluripotency genes and differentiation genes in response to 
developmental signaling (Boyer et al., 2005; Kim et al., 2008). To achieve this 
flexibility in gene expression ESCs maintain an “open” chromatin structure that 
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contains more euchromatin than heterochromatin (Meshorer and Misteli, 2006) 
as well as unique patterns of histone modifications. Various protein complexes 
can remodel this chromatin structure (and thus regulate gene expression 
patterns) by modifying nucleosome positioning as well as through 
posttranslational modification of histones (Fazzio and Panning, 2010). 
The Nucleosome Remodeling and Deacetylase (NuRD) complex is unique 
amongst chromatin regulators because it couples ATP-dependent nucleosome 
remodeling activity with histone modification (deacetylase) activity (Tong et al., 
1998; Wade et al., 1998; Xue et al., 1998; Zhang et al., 1998). NuRD alters 
chromatin structure near its target genes by repositioning local nucleosomes to 
block the binding of transcriptional machinery at gene promoters, thus functioning 
primarily as a co-repressor (Denslow and Wade, 2007). The NuRD subunit 
MBD3 can also act as a transcriptional repressor, as we have observed that 
nucleosome occupancy is decreased and RNA Polymerase II recruitment is 
increased at MBD3 target genes in Mbd3 knockdown (KD) ESCs (Yildirim et al., 
2011). However, three MBD3 isoforms (MBD3A, B and C) are expressed in 
mouse ESCs and only MBD3A has a full-length MBD (Kaji et al., 2006). Thus, 
the possibility exists for formation of multiple NuRD complexes of varying subunit 
combinations and functional specificities. For example, each MBD3 isoform could 
form unique complexes (with NuRD and/or other chromatin regulators) and 
recruit said complexes to its genomic targets through different mechanisms. We 
sought to investigate this possibility in the present study.  
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Here, we have characterized a unique variant of the NuRD chromatin 
remodeling complex that harbors MBD3C, an ESC-specific isoform of MBD3, as 
well as the histone H3 binding protein WDR5. MBD3C is expressed almost 
exclusively in ESCs via an alternative CpG island (CGI)–containing promoter 
located in the second intron of the Mbd3 gene. We further show that MBD3C 
contains a unique 50–amino acid N-terminus that is necessary for WDR5 
interaction. MBD3C interacts with the WDR5 H3 binding pocket through an 
arginine-containing motif also utilized by MLL1 for WDR5 binding. RNA-seq 
analysis revealed that the three MBD3 isoforms are largely redundant for gene 
regulation, since knockout (KO) of all three isoforms had a more severe effect on 
gene expression than individual KO of Mbd3c or simultaneous KO of Mbd3a and 
b. Importantly, the WDR5-interaction domain of Mbd3c is critical for its gene 
regulatory function, suggesting that WDR5 plays critical roles in MBD3C/NuRD 
complex.  
 
RESULTS AND DISCUSSION 
MBD3C/NuRD co-purifies with WDR5 
To identify proteins co-purifying with MBD3 in ESCs, we used a cell line in 
which one copy of endogenous MBD3 is fused to a C-terminal 6xHis-3xFLAG tag 
(Mbd3-H3F; (Yildirim et al., 2011), allowing for affinity purification of MBD3A, B, 
and C simultaneously (Figures 2.1A and 2.1B). LC-MS/MS of purified MBD3 
complexes identified all canonical NuRD subunits, several of which were 
subsequently confirmed by western blot (Figure 2.1C and Table 2.1).  
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Consistent with recent mass spectrometry analyses of NuRD components 
(Bode et al., 2016), we detected an interaction between MBD3 and the SET/MLL 
complex component WDR5 (Figures 2.1C and 2.1D;  Table 2.1). The MLL 
complex is a histone methyltransferase that catalyzes methylation of H3K4, a 
mark found at transcriptionally active genes (Bernstein et al., 2002; Santos-Rosa 
et al., 2002). WDR5 binds the histone H3 tail in vitro and is essential for H3K4 
trimethylation and MLL complex formation (Couture et al., 2006; Dou et al., 2006; 
Ruthenburg et al., 2006; Schuetz et al., 2006; Wysocka et al., 2005). We did not 
observe any other MLL subunits co-purifying with MBD3 (Figure 2.1C and Table 
2.1), suggesting WDR5 interacts with MBD3/NuRD independently of MLL 
complex. To validate these data, we performed co-immunoprecipitation (co-IP) 
assays. Interestingly, WDR5 IP pulled down MBD3C, but not the more abundant 
isoforms, MBD3A and B (Figure 2.1E). These data suggest that WDR5 interacts 
specifically with this smallest and least characterized isoform of MBD3.  
To further investigate the composition of the MBD3C/NuRD complex, we 
generated an ESC line expressing Mbd3c-H3F from a viral vector, such that only 
the MBD3C isoform is epitope-tagged. To this end, we first performed 5’ rapid 
amplification of cDNA ends (5’RACE) to obtain the Mbd3c coding sequence. We 
found that MBD3C is translated from a start codon within intron 2 of the Mbd3 
gene, consistent with a recent report (Santos et al., 2014). Thus, MBD3C lacks 
the entire MBD and contains a unique 50–amino acid N-terminus (Figure 2.2A). 
MBD3C-H3F complexes were affinity purified (Figure 2.2B) and analyzed by LC-
MS/MS. As expected, WDR5 co-purifies with MBD3C-H3F, but not MBD3A-H3F 
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(Figures 2.2C and 2.2D; Table 2.2). Importantly, we found that WDR5 interaction 
was disrupted by deletion of the unique MBD3C N-terminus (MBD3CΔN; Figures 
2.2C and 2.2D), demonstrating that this domain is necessary for WDR5 binding. 
Co-IP experiments confirmed these results (Figure 2.2E). Furthermore, we 
observed that MBD3C-H3F, MBD3A-H3F, and MBD3CΔN-H3F all co-purify with 
the canonical NuRD subunits (Figure 2.2C; 2.2D; Table 2.2). Together with data 
showing that WDR5 also co-purifies with NuRD subunits (Figure 2.1D; (Bode et 
al., 2016) and that MBD3C co-fractionates exclusively with NuRD subunit MTA1 
(Figure 2.2F) these data demonstrate that MBD3C assembles into a canonical 
NuRD complex that also includes WDR5. Although the MBD3 MBD was 
previously shown to directly interact with NuRD subunits HDAC1 and MTA2 in 
vitro (Saito and Ishikawa, 2002), our findings suggest that HDAC1 and MTA2 can 
also associate with the NuRD complex by MBD-independent mechanisms in 
vivo. Additionally, while the unique MBD3C N-terminus is required for interaction 
with WDR5, it is dispensable for interaction with the other known NuRD subunits 
(Figure 2.2D and Table 2.2). 
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Figure 2.1: The NuRD subunit MBD3 co-purifies with WDR5  
(A) Silver stain of MBD3-H3F complex. (B) Left: Schematic of the three MBD3 
isoforms in ESCs. MBD3A contains a methyl-binding domain (MBD) that is 
truncated in MBD3B and absent in MBD3C. The purple box signifies the unique 
Mbd3 N-terminal 50 amino acids. Right: Western blot of Mbd3 in ESCs and 
MEFs. Actin serves as a loading control.  (C) Western blot of purified complex 
from (A) showing interaction of MBD3 with NuRD subunits (left) and with WDR5 
or MLL subunit ASH2L (right). (D) Western blots of NuRD subunits from purified 
H3F-WDR5 complexes in WT, Mbd3c KO or Mbd3abc KO ESCs. (E) Western 
blots for MBD3-H3F or WDR5 upon IP of each. Asterisks (*), IgG.   
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Table 2.1: Proteins identified in LC-MS/MS of endogenous Mbd3-H3F ESCs 
 
Protein Name Description # of peptides 
Chd4 Chromodomain-helicase-DNA-binding protein 4 252 
Mta2 Metastasis-associated protein MTA2 324 
Mta3 Metastasis-associated protein MTA3 250 
Mta1 Metastasis-associated protein MTA1 206 
Gatad2a/p66-alpha Transcriptional repressor p66 alpha 351 
Gatad2b/p66-beta Transcriptional repressor p66-beta 341 
Mthfd1l Monofunctional C1-tetrahydrofolate synthase, 
mitochondrial 
82 
Lima1 LIM domain and actin-binding protein 1 102 
Actb Actin, cytoplasmic 1 93 
Actg1 Actin, cytoplasmic 2 93 
Acta2 Actin, aortic smooth muscle 61 
Actg2 Actin, gamma-enteric smooth muscle 61 
Actc1 Actin, alpha cardiac muscle 1 61 
Acta1 Actin, alpha skeletal muscle 61 
Hspa8 Heat shock cognate 71 kDa protein 56 
Hspa5 78 kDa glucose-regulated protein 18 
Hspa9 Stress-70 protein, mitochondrial 12 
Mbd3 Methyl-CpG-binding domain protein 3 162 
Mbd2 Methyl-CpG-binding domain protein 2 28 
Tubb2b Tubulin beta-2B chain 67 
Tubb5 Tubulin beta-5 chain 77 
Tubb4b Tubulin beta-4B chain 73 
Tubb4a Tubulin beta-4A chain 54 
Tubb3 Tubulin beta-3 chain 47 
Tubb6 Tubulin beta-6 chain 33 
Stk38 Serine/threonine-protein kinase 38 116 
Stk38l Serine/threonine-protein kinase 38-like 16 
Trim28 Transcription intermediary factor 1-beta 37 
Myo1c Unconventional myosin-Ic 34 
Myo1f Unconventional myosin-If 7 
Hsp90ab1 Heat shock protein HSP 90-beta 32 
Hsp90aa1 Heat shock protein HSP 90-alpha 31 
Hsp90b1 Endoplasmin 4 
Hdac1 Histone deacetylase 1 132 
Hdac2 Histone deacetylase 2 99 
Tuba1b Tubulin alpha-1B chain 62 
Tuba1c Tubulin alpha-1C chain 61 
Tuba1a Tubulin alpha-1A chain 59 
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Tuba4a Tubulin alpha-4A chain 49 
Tuba3a Tubulin alpha-3 chain 45 
Tuba8a Tubulin alpha-8 chain 31 
Rbbp4/RbAp48 Retinoblastoma binding protein 4 120 
Rbbp7/RbAp46 Retinoblastoma binding protein 7 91 
Prpf3 U4/U6 small nuclear ribonucleoprotein Prp3 31 
Sall4 Sal-like protein 4 54 
Sall1 Sal-like protein 1 26 
Sall3 Sal-like protein 3 12 
Actn4 Alpha-actinin-4 23 
Actn1 Alpha-actinin-1 13 
Actn2 Alpha-actinin-2 4 
Myh10 Myosin-10 21 
Myh9 Myosin-9 6 
L1td1 LINE-1 type transposase domain-containing protein 1 13 
Tmod3 Tropomodulin-3 23 
Mccc1 Methylcrotonoyl-CoA carboxylase subunit alpha, 
mitochondrial 
17 
Ppm1b Protein phosphatase 1B 19 
Msh2 DNA mismatch repair protein Msh2 15 
Gapdh Glyceraldehyde-3-phosphate dehydrogenase 16 
Atp5a1 ATP synthase subunit alpha, mitochondrial 10 
Myo1e Unconventional myosin-Ie 20 
Myo1f Unconventional myosin-If 7 
Setx Probable helicase senataxin 20 
Ruvbl1 RuvB-like 1 9 
Wdr5 WD repeat-containing protein 5 15 
Tcp1 T-complex protein 1 subunit alpha 9 
Hdac6 Histone deacetylase 6 11 
Cct8 T-complex protein 1 subunit theta 9 
Rest RE1-silencing transcription factor 12 
Kpna3 Importin subunit alpha-3 11 
Kpna4 Importin subunit alpha-4 7 
Mccc2 Methylcrotonoyl-CoA carboxylase beta chain, 
mitochondrial 
9 
Cct5 T-complex protein 1 subunit epsilon 7 
Cct6a T-complex protein 1 subunit zeta 8 
Kpna2 Importin subunit alpha-2 6 
Hnrnph1 Heterogeneous nuclear ribonucleoprotein H 6 
Prpf4 U4/U6 small nuclear ribonucleoprotein Prp4 9 
Ruvbl2 RuvB-like 2 5 
Thrap3 Thyroid hormone receptor-associated protein 3 12 
Myo1b Unconventional myosin-Ib 6 
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Ogt UDP-N-acetylglucosamine--peptide N-
acetylglucosaminyltransferase 110 kDa subunit 
6 
Kpnb1 Importin subunit beta-1 6 
Pabpc1 Polyadenylate-binding protein 1 6 
Gart Trifunctional purine biosynthetic protein adenosine-3 5 
Cct3 T-complex protein 1 subunit gamma 7 
Hspd1 60 kDa heat shock protein, mitochondrial 5 
Capzb F-actin-capping protein subunit beta 5 
Cct2 T-complex protein 1 subunit beta 4 
Mcm3 DNA replication licensing factor MCM3 4 
Hnrnpu Heterogeneous nuclear ribonucleoprotein U 4 
Ppp2r1a Serine/threonine-protein phosphatase 2A 65 kDa 
regulatory subunit A alpha isoform 
5 
Adsl Adenylosuccinate lyase 3 
D1Pas1 Putative ATP-dependent RNA helicase Pl10 3 
Ivns1abp Influenza virus NS1A-binding protein homolog 3 
Myo1d Unconventional myosin-Id 5 
Capza2 F-actin-capping protein subunit alpha-2 4 
Capza1 F-actin-capping protein subunit alpha-1 4 
Mapk1 Mitogen-activated protein kinase 1 5 
Eef2 Elongation factor 2 5 
Col1a1 Collagen alpha-1(I) chain 3 
Canx Calnexin 3 
Ddx5 Probable ATP-dependent RNA helicase DDX5 3 
Bclaf1 Bcl-2-associated transcription factor 1 7 
Vim Vimentin 3 
Ppp2r2a Serine/threonine-protein phosphatase 2A 55 kDa 
regulatory subunit B alpha isoform 
3 
Ipo5 Importin-5 3 
Mcm5 DNA replication licensing factor MCM5 2 
Eef1a1 Elongation factor 1-alpha 1 6 
Rplp0 60S acidic ribosomal protein P0 2 
Psmd1 26S proteasome non-ATPase regulatory subunit 1 8 
Prmt5 Protein arginine N-methyltransferase 5 3 
Rps3a 40S ribosomal protein S3a 3 
Tra2b Transformer-2 protein homolog beta 1 
Eif3b Eukaryotic translation initiation factor 3 subunit B 7 
Cse1l Exportin-2 2 
Caprin1 Caprin-1 2 
Gfap Glial fibrillary acidic protein 11 
Top2a DNA topoisomerase 2-alpha 1 
Nup107 Nuclear pore complex protein 107 2 
Eif3c Eukaryotic translation initiation factor 3 subunit C 2 
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Kpna2 Importin subunit alpha-1 1 
Dhx15 Putative pre-mRNA-splicing factor ATP-dependent 
RNA helicase DHX15 
1 
Otud4 OTU domain-containing protein 4 1 
Nedd4 E3 ubiquitin-protein ligase NEDD4 1 
Akap8 A-kinase anchor protein 8 2 
Smarcc1 SWI/SNF complex subunit SMARCC1 1 
Glud1 Glutamate dehydrogenase 1, mitochondrial 2 
Psmd11 26S proteasome non-ATPase regulatory subunit 11 1 
Hnrnpc Heterogeneous nuclear ribonucleoproteins C1/C2 2 
Ddx39A ATP-dependent RNA helicase DDX39A 1 
Prpsap2 Phosphoribosyl pyrophosphate synthase-associated 
protein 2 
1 
Rps2 40S ribosomal protein S2 1 
Tufm Elongation factor Tu, mitochondrial 1 
Psmc3 26S protease regulatory subunit 6A 3 
G3bp1 Ras GTPase-activating protein-binding protein 1 3 
Mcm7 DNA replication licensing factor MCM7 2 
Psmd2 26S proteasome non-ATPase regulatory subunit 2 3 
Tdh L-threonine 3-dehydrogenase, mitochondrial 1 
Hnrnpl Heterogeneous nuclear ribonucleoprotein L 1 
Rbm10 RNA-binding protein 10 2 
Jak1 Tyrosine-protein kinase JAK1 1 
Hist1h4 Histone H4 1 
Npm1 Nucleophosmin 1 
Matr3 Matrin-3 1 
Hnrnpm Heterogeneous nuclear ribonucleoprotein M 1 
H2afz Histone H2A.Z 1 
Dnajb11 DnaJ homolog subfamily B member 11 1 
Rpsa 40S ribosomal protein SA 1 
Tubg1 Tubulin gamma-1 chain 1 
Asap2 Arf-GAP with SH3 domain, ANK repeat and PH 
domain-containing protein 2 
15 
Hnrnpk Heterogeneous nuclear ribonucleoprotein K 1 
Psmd13 26S proteasome non-ATPase regulatory subunit 13 1 
H3f3c Histone H3.3C 1 
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Figure 2.2: MBD3c contains a unique 50-amino acid N-terminus that is 
required for interaction with WDR5  
 
(A) Schematic of the N-terminal Mbd3c DNA and MBD3C protein sequences 
determined by 5’RACE. Exons are indicated by numbered blue boxes, introns by 
connecting black lines. The sequence of Mbd3 intron 2 is shown, with the Mbd3c 
N-terminus in red. The amino acid sequence of the MBD3C N-terminus derived 
from intron 2 is shown (represented by the gray box in the Mbd3c gene). (B) 
Silver stain of MBD3 complex expressing individually H3F-tagged MBD3 
isoforms. (C) Western blot of purified complexes from (B) showing interaction 
with WDR5 and NuRD subunits. (D) Table of peptide counts from mass spec 
analysis of individually FLAG-tagged MBD3 isoforms. (E) WDR5 IP or FLAG IP 
from individually tagged MBD3C-H3F and MBD3CΔN-H3F ESCs. (F) Glycerol 
gradient analysis of Mbd3-H3F nuclear extracts.  	  
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Table 2.2: Proteins identified in LC-MS/MS of Mbd3a-H3F, Mbd3c-H3F, and 
Mbd3cΔN-H3F ESCs 
 
Protein Name Description # of peptides 
Mbd3a-H3F 
# of peptides 
Mbd3c-H3F 
# of peptides 
Mbd3cΔN-H3F 
Chd4 Chromodomain-helicase-DNA-
binding protein 4 
322 291 365 
Setx Probable helicase senataxin 135 100 106 
Dnaja1 DnaJ homolog subfamily A 
member 1 
9 15 28 
Mta2 Metastasis-associated protein 
MTA2 
396 503 493 
Mta1 Metastasis-associated protein 
MTA1 
382 203 425 
Mta3 Metastasis-associated protein 
MTA3 
381 375 445 
Mthfd1l Monofunctional C1-
tetrahydrofolate synthase, 
mitochondrial 
130 286 218 
Gatad2a/p66-
alpha 
Transcriptional repressor p66 
alpha 
428 527 674 
Gatad2b/p66-
beta 
Transcriptional repressor p66-
beta 
343 414 543 
Hspa8 Heat shock cognate 71 kDa 
protein 
114 169 181 
Hspa9 Stress-70 protein, 
mitochondrial 
34 32 68 
Hspa5 78 kDa glucose-regulated 
protein 
51 61 64 
Stk38 Serine/threonine-protein 
kinase 38 
313 371 306 
Stk38l Serine/threonine-protein 
kinase 38-like 
67 115 92 
Prpf3 U4/U6 small nuclear 
ribonucleoprotein Prp3 
192 30 108 
Hdac1 Histone deacetylase 1 268 271 308 
Hdac2 Histone deacetylase 2 193 183 213 
Actb Actin, cytoplasmic 1 193 263 220 
Brg1 Transcription activator BRG1 57 22 64 
Mbd3 Methyl-CpG-binding domain 
protein 3 
213 208 320 
Hsp90ab1 Heat shock protein HSP 90-
beta 
81 53 76 
Hsp90aa1 Heat shock protein HSP 90-
alpha 
67 44 64 
Vim Vimentin 28 83 26 
Pabpc1 Polyadenylate-binding protein 
1 
31 46 31 
Wdr5 WD repeat-containing protein 
5 
2 157 3 
Ruvbl2 RuvB-like 2 22 51 46 
Mccc2 Methylcrotonoyl-CoA 
carboxylase beta chain, 
mitochondrial 
24 41 28 
Rps3a 40S ribosomal protein S3a 47 49 47 
Tuba1b Tubulin alpha-1B chain 64 162 126 
Tcp1 T-complex protein 1 subunit 
alpha 
15 25 19 
Mccc1 Methylcrotonoyl-CoA 
carboxylase subunit alpha, 
mitochondrial 
20 53 56 
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Tmod3 Tropomodulin-3 34 64 75 
Hnrnpc Heterogeneous nuclear 
ribonucleoproteins C1/C2 
20 48 44 
Mybbp1a Myb-binding protein 1A 11 42 28 
Ncl Nucleolin 3 39 17 
Ruvbl1 RuvB-like 1 16 43 33 
Sall4 Sal-like protein 4 9 56 14 
Sall1 Sal-like protein 1 8 18 13 
Prpf4 U4/U6 small nuclear 
ribonucleoprotein Prp4 
60 15 56 
Rpl7 60S ribosomal protein L7 31 49 32 
Rbbp4/RbAp48 Retinoblastoma binding 
protein 4 
200 250 280 
Rbbp7/RbAp46 Retinoblastoma binding 
protein 7 
163 157 180 
Cct7 T-complex protein 1 subunit 
eta 
20 25 22 
Rbm10 RNA-binding protein 10  27 19 
Tubb5 Tubulin beta-5 chain 61 97 104 
Flii Protein flightless-1 homolog 1 47 3 
Rpl7a 60S ribosomal protein L7a 23 53 31 
Pkm Pyruvate kinase isozymes 
M1/M2 
18 31 21 
Actl6a Actin-like protein 6A 30 11 40 
Myo1c Myosin-Ic 22 50 19 
Rps4x 40S ribosomal protein S4, X 
isoform 
20 48 53 
Rpl6 60S ribosomal protein L6 33 83 37 
Prpf31 U4/U6 small nuclear 
ribonucleoprotein Prp31 
25 16 50 
Rpl4 60S ribosomal protein L4 17 65 29 
Jak1 Tyrosine-protein kinase JAK1 20 32 39 
Rps3a 40S ribosomal protein S3 23 31 40 
Eif4a3 Eukaryotic initiation factor 4A-
III 
14 22 30 
Eif4a1 Eukaryotic initiation factor 4A-I 3 5 14 
Cct8 T-complex protein 1 subunit 
theta 
13 17 20 
Hdac6 Histone deacetylase 6 26 47 34 
Atp5a1 ATP synthase subunit alpha, 
mitochondrial 
20 22 16 
Csnk2a2 Casein kinase II subunit alpha 7 20 25 
Lrrfip2 Leucine-rich repeat flightless-
interacting protein 2 
3 48 9 
Cct2 T-complex protein 1 subunit 
beta 
22 18 23 
Gapdh Glyceraldehyde-3-phosphate 
dehydrogenase 
42 64 89 
Psmc5 26S protease regulatory 
subunit 8 
5 13 23 
Psmc1 26S protease regulatory 
subunit 4 
 9 2 
Trim28 Transcription intermediary 
factor 1-beta 
3 39 25 
Cct6a T-complex protein 1 subunit 21 31 23 
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zeta 
Thrap3 Thyroid hormone receptor-
associated protein 3 
48 30 52 
Bclaf1 Bcl-2-associated transcription 
factor 1 
21 8 33 
Coro1c Coronin-1C  48  
Rpl3 60S ribosomal protein L3 25 74 45 
Atp5b ATP synthase subunit beta, 
mitochondrial 
16 14 11 
Hnrnpf Heterogeneous nuclear 
ribonucleoprotein F 
11 52 38 
Hnrnph1 Heterogeneous nuclear 
ribonucleoprotein H 
14 31 28 
Hnrnph2 Heterogeneous nuclear 
ribonucleoprotein H2 
12 20 18 
Actn4 Alpha-actinin-4 1 40 16 
Ddx3x ATP-dependent RNA helicase 
DDX3X 
5 21 22 
Ddx5 Probable ATP-dependent 
RNA helicase DDX5 
 10 8 
Ddx17 Probable ATP-dependent 
RNA helicase DDX17 
 4 7 
Phb2 Prohibitin-2 22 5 30 
Spin1 Spindlin-1 26 30 29 
Ddb1 DNA damage-binding protein 
1 
 19 6 
Tra2b Transformer-2 protein 
homolog beta 
34 17 38 
Tra2a Transformer-2 protein 
homolog alpha 
18 9 17 
Tufm Elongation factor Tu, 
mitochondrial 
2 10 24 
Psmc4 26S protease regulatory 
subunit 6B 
 7 16 
Rps2 40S ribosomal protein S2 20 48 58 
Ppm1b Protein phosphatase 1B 20 39 51 
Ppm1a Protein phosphatase 1A 5 8 8 
Rplp0 60S acidic ribosomal protein 
P0 
16 48 28 
Psmd3 26S proteasome non-ATPase 
regulatory subunit 3 
4 17 9 
Capza1 F-actin-capping protein 
subunit alpha-1 
17 19 15 
Capza2 F-actin-capping protein 
subunit alpha-2 
15 15 12 
Dars Aspartyl-tRNA synthetase, 
cytoplasmic 
8 14 7 
Cct3 T-complex protein 1 subunit 
gamma 
14 21 19 
Ybx1 Nuclease-sensitive element-
binding protein 1 
6 16 15 
Ybx3 DNA-binding protein A 2 13 7 
Hspd1 60 kDa heat shock protein, 
mitochondrial 
6 15 14 
Lmnb1 Lamin-B1  18 3 
Psmd11 26S proteasome non-ATPase 
regulatory subunit 11 
3 16 22 
Wdr1 WD repeat-containing protein 
1 
 20  
Ssb Lupus La protein homolog 8 17 16 
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Myh10 Myosin-10 5 17 15 
Myh9 Myosin-9 9 6 8 
Cct5 T-complex protein 1 subunit 
epsilon 
4 14 16 
Eftud2 116 kDa U5 small nuclear 
ribonucleoprotein component 
 15 9 
Kpna3 Importin subunit alpha-3 22 34 32 
Eef1a1 Elongation factor 1-alpha 1 30 46 62 
Cct4 T-complex protein 1 subunit 
delta 
17 20 15 
Prpf19 Pre-mRNA-processing factor 
19 
10 17 12 
Serbp1 Plasminogen activator inhibitor 
1 RNA-binding protein 
4 13 8 
Eif3e Eukaryotic translation initiation 
factor 3 subunit E 
2 9 10 
Sf3b3 Splicing factor 3B subunit 3  17 2 
Hnrnpu Heterogeneous nuclear 
ribonucleoprotein U 
8 38 18 
Dnaja2 DnaJ homolog subfamily A 
member 2 
5 9 20 
Lima1 LIM domain and actin-binding 
protein 1 
 32 3 
Dnajb11 DnaJ homolog subfamily B 
member 11 
5 7 11 
Dhx15 Putative pre-mRNA-splicing 
factor ATP-dependent RNA 
helicase DHX15 
5 16 10 
Ivns1abp Influenza virus NS1A-binding 
protein homolog 
10 21 14 
G3bp2 Ras GTPase-activating 
protein-binding protein 2 
7 19 13 
G3bp1 Ras GTPase-activating 
protein-binding protein 1 
4 8 8 
Hnrnpk Heterogeneous nuclear 
ribonucleoprotein K 
2 23 8 
Hnrnpl Heterogeneous nuclear 
ribonucleoprotein L 
3 11 10 
Sptan1 Spectrin alpha chain, brain  16 2 
Igf2bp1 Insulin-like growth factor 2 
mRNA-binding protein 1 
1 20 3 
Rpl8 60S ribosomal protein L8 24 55 27 
Hist1h1c Histone H1.2 22 8 20 
Aifm1 Apoptosis-inducing factor 1, 
mitochondrial 
2 11 7 
Nudc Nuclear migration protein 
nudC 
6 14 18 
Prmt5 Protein arginine N-
methyltransferase 5 
8 13 14 
Eif3f Eukaryotic translation initiation 
factor 3 subunit F 
 8 10 
Cdc5l Cell division cycle 5-related 
protein 
 11 3 
Cdk1 Cyclin-dependent kinase 1 5 16 8 
Ilf2 Interleukin enhancer-binding 
factor 2 
7 12 14 
Elavl1 ELAV-like protein 1 12 13 21 
Hnrnpm Heterogeneous nuclear 
ribonucleoprotein M 
1 18 3 
Rps6 40S ribosomal protein S6 5 30 17 
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Psmd1 26S proteasome non-ATPase 
regulatory subunit 1 
2 14 9 
Capzb F-actin-capping protein 
subunit beta 
12 12 15 
Psmd2 26S proteasome non-ATPase 
regulatory subunit 2 
17 8 12 
Polr1c DNA-directed RNA 
polymerases I and III subunit 
RPAC1 
2 7 8 
Slc25a5 ADP/ATP translocase 2 7 31 28 
Twf1 Twinfilin-1  12 4 
Atp5c1 ATP synthase subunit gamma, 
mitochondrial 
8 10 12 
Puf60 Poly(U)-binding-splicing factor 
PUF60 
 11 3 
Kpna2 Importin subunit alpha-2 11 17 16 
Dnaja3 DnaJ homolog subfamily A 
member 3, mitochondrial 
2 6 11 
Rpsa 40S ribosomal protein SA 3 6 9 
Sptbn1 Spectrin beta chain, brain 1  8  
Kpnb1 Importin subunit beta-1 4 9 11 
Dnajb6 DnaJ homolog subfamily B 
member 6 
4 6 10 
Eif3i Eukaryotic translation initiation 
factor 3 subunit I 
5 13 11 
Ssrp1 FACT complex subunit 
SSRP1 
9 4 9 
Sf3b1 Splicing factor 3B subunit 1 1 14 2 
Otud4 OTU domain-containing 
protein 4 
8 4  
Srsf7 Serine/arginine-rich splicing 
factor 7 
18 11 30 
Ppp2r1a Serine/threonine-protein 
phosphatase 2A 65 kDa 
regulatory subunit A alpha 
isoform 
 9  
Mov10 Putative helicase MOV-10  9 1 
Pgam5 Serine/threonine-protein 
phosphatase PGAM5, 
mitochondrial 
4 13 11 
Rnps1 RNA-binding protein with 
serine-rich domain 1 
6  11 
Eif3c Eukaryotic translation initiation 
factor 3 subunit C 
 8 9 
Ilf3 Interleukin enhancer-binding 
factor 3 
 9 8 
Myo1b Myosin-Ib 4 8  
Tdh L-threonine 3-dehydrogenase, 
mitochondrial 
8 2 22 
Nono Non-POU domain-containing 
octamer-binding protein 
3 13 6 
Sfpq Splicing factor, proline- and 
glutamine-rich 
 15 12 
Npm1 Nucleophosmin 2 13 10 
Sun2 SUN domain-containing 
protein 2 
9 3 6 
Rpl11 60S ribosomal protein L11 14 15 27 
Mga MAX gene-associated protein  6  
U2af2 Splicing factor U2AF 65 kDa 
subunit 
 13 6 
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Eif3b Eukaryotic translation initiation 
factor 3 subunit B 
 12 7 
C1qbp Complement component 1 Q 
subcomponent-binding 
protein, mitochondrial 
2  12 
Prdx1 Peroxiredoxin-1 17 29 42 
Gsn Gelsolin 11 8 4 
Rps8 40S ribosomal protein S8 13 49 23 
Psmc3 26S protease regulatory 
subunit 6A 
2 6 11 
Rpl23 60S ribosomal protein L23 4 26 23 
Ap2m1 AP-2 complex subunit mu   8 
Ctbp2 C-terminal-binding protein 2  7 11 
Rpl13 60S ribosomal protein L13 3 44 14 
Fbl rRNA 2'-O-methyltransferase 
fibrillarin 
8 9 14 
Srsf1 Serine/arginine-rich splicing 
factor 1 
9 8 11 
Wdr77 Methylosome protein 50 3 4 11 
Rps9 40S ribosomal protein S9 13 30 24 
Rpl14 60S ribosomal protein L14 1 25 5 
Stmn2 Stathmin-2 4 14 16 
Rps23 40S ribosomal protein S23 7 26 20 
Rps26 40S ribosomal protein S26  19 7 
Rpl21 60S ribosomal protein L21  22 9 
Rpl18 60S ribosomal protein L18  13 7 
Ubb Polyubiquitin-B 5 16 12 
Rpl27a 60S ribosomal protein L27a 6 12 5 
Rps11 40S ribosomal protein S11 12 19 21 
Alb Serum albumin 11 13 12 
Hist1h3a Histone H3.1 6 11 10 
Rpl34 60S ribosomal protein L34  8  
B3galt5 Beta-1,3-galactosyltransferase 
5 
 10  
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The WDR5 histone H3 binding pocket is required for interaction with 
MBD3C 
 
To gain insight into the functions of the MBD3C-WDR5 interaction, we 
dissected the domains within MBD3C and WDR5 important for their interaction. 
WDR5 contains two binding surfaces on opposite sides of the protein, one that 
binds the histone H3 N-terminal tail or the SET/MLL complex subunit MLL1, and 
another that binds both the SET/MLL subunit RBBP5 (Figure 2.3A; (Avdic et al., 
2011; Odho et al., 2010; Patel et al., 2008; Song and Kingston, 2008) and long 
noncoding RNAs (Yang et al., 2014). To test whether MBD3C interacts with 
either WDR5 binding surface, we performed co-IPs in 293T cells co-transfected 
with vectors expressing MBD3C-H3F and FLAG-tagged point mutants from both 
binding surfaces of WDR5: D107A on the H3K4/MLL1 binding surface and 
F266A, K250A, and R181A on the RBBP5/RNA binding surface (Yang et al., 
2014). We found that the F266A, K250A, and R181A mutants of WDR5 co-IP 
with antibodies recognizing endogenous MBD3 (Figure 2.3B). In contrast, the 
D107A mutant was absent from MBD3 immunoprecipitates, suggesting that 
MBD3C binds near or within the WDR5 H3K4/MLL1 binding pocket. 
To extend these findings, we generated a series of truncation mutants of 
the 50–amino acid MBD3C N-terminus to pinpoint the residues necessary for 
binding (Figure 2.3C). Deletion of the first 40 amino acids of H3F-tagged MBD3C 
did not disrupt the interaction with V5-tagged WDR5 (Figure 2.3D). However, 
upon deletion of amino acids 41-50 of MBD3C, interaction with WDR5 was 
completely lost (Figure 2.3E), as we observed for MBD3C mutants lacking amino 
acids 1-50 (Figures 2.2C, E and Figure 2.3D). Furthermore, an N-terminal fusion 
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of amino acids 41-50 to the MBD3A isoform was sufficient to allow MBD3A to 
bind WDR5 (Figure 2.3F). These data demonstrate that amino acids 41-50 of 
MBD3C mediate WDR5 binding (see also Figure 2.1D). 
MLL1, KANSL1, and histone H3 all bind the same domain on WDR5 via a 
two amino acid alanine-arginine (AR) motif present on each protein (Couture et 
al., 2006; Han et al., 2006; Patel et al., 2008; Ruthenburg et al., 2006; Schuetz et 
al., 2006; Song and Kingston, 2008); (Dias et al., 2014); Figures 2.3A and 2.3G). 
MBD3C contains an AR dipeptide within its N-terminal WDR5 binding domain 
(A42-R43; Figure 2.3G), which we hypothesized to be necessary for WDR5 
binding. Confirming our hypothesis, an R43A mutant of MBD3C failed to pull 
down WDR5 (Figure 2.3E). Together, these data indicate that MBD3C, histone 
H3, and MLL1 use a common motif to bind the same surface of WDR5. We 
observed slightly reduced MBD3C protein levels in cells expressing mutants of 
MBD3C or WDR5 that disrupt MBD3C–WDR5 binding (Figures 2.3D and 2.3E), 
raising the possibility that interaction with WDR5 plays a role in stabilizing 
MBD3C.  
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Figure 2.3: The WDR5 histone H3 binding pocket is required to bind MBD3C 
 
(A) PyMol depiction of WDR5 crystal structure (PDB:2GNQ) showing the 
H3K4/MLL1 (left) and RBBP5 (right) binding pockets. Residues individually 
mutated to alanine (Yang et al., 2014) are shown in magenta. Residues 
necessary for MLL1 R3761 or histone H3R2 binding are shown in orange. (B) 
Co-IPs with MBD3 antibody from 293T cells co-transfected with expression 
vectors carrying MBD3C-H3F and indicated FLAG-tagged WDR5 mutants. (C) 
Schematic of Mbd3c N-terminal mutant constructs used in (D) and (E). (D-F) Co-
IPs with MBD3 antibody in 293T cells performed as in (B), using V5-tagged 
WDR5 constructs and H3F-tagged MBD3 constructs. For “c41-50−MBD3A”, 
MBD3C amino acids 41-50 were fused to the N-terminus of the MBD3A isoform. 
(G) Alignment of the MBD3C N-terminus with WDR5-binding regions of mouse 
MLL1, KANSL1, and histone H3. 	 	
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Mbd3c expression is largely restricted to pluripotent stem cells 
The Mbd3c isoform appears to be highly expressed only in ESCs, as it is 
absent or weakly expressed in mouse embryonic fibroblasts (MEFs) and all adult 
tissues tested (Figures 2.1B and 2.4A). To determine when Mbd3c expression is 
lost during differentiation we subjected ESCs to a 10-day embryoid body (EB) 
differentiation time course. We observed that MBD3C protein was lost between 
days 4 and 6 of the time course with kinetics similar to loss of OCT4 protein 
during differentiation (Figure 2.4A). 
Next, we tested whether Mbd3c expression was restored upon 
reprogramming of differentiated cells to induced pluripotent stem cells. Primary 
MEFs were infected with doxycycline (dox)-inducible lentiviruses expressing 
reprogramming factors OCT4, SOX2, and KLF4 marked with an mCherry 
reporter (OSK-mCherry), L-MYC, and a lentiviral EOS-EGFP reporter specifically 
activated in pluripotent cells (Hotta et al., 2009). Infected cells were cultured with 
dox for 20 days. After an additional 10 days in the absence of dox, cells were 
imaged and stained for alkaline phosphatase to verify silencing of OSK-mCherry 
and presence of ESC-like colonies (Figures 2.4C and 2.4D). Lysates for western 
blots were prepared from expanded iPSC colonies picked at 30 days. We 
observed that reprogrammed iPSC colonies express Mbd3c  (Figure 2.4E). 
These data demonstrate Mbd3c expression is restored when somatic cells are 
reprogrammed to iPSCs. 
 Finally, to investigate how Mbd3c expression might be silenced during 
differentiation, we performed bisulfite pyrosequencing analysis on the Mbd3c 
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promoter during an EB differentiation time course. The Mbd3 gene contains a 
~350bp CGI which spans exon 2 and part of intron 2, and overlaps with the 
sequence encoding the MBD3C N-terminal domain (Figure 2.5A). We measured 
methylation of 11 individual CpGs within the Mbd3c promoter and observed a 
large increase in methylation at all sites over the differentiation time course 
(Figure 2.5B). Methylation increased most dramatically around day 4, which 
corresponds to the timing of MBD3C loss during differentiation (Figure 2.4A). 
Therefore, silencing of Mbd3c expression during differentiation is likely due to 
increased methylation of the Mbd3c promoter CGI. 
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Figure 2.4: Mbd3c expression is largely restricted to pluripotent cells 
 
(A) Western blot of MBD3 from lysates of the indicated mouse tissues. Actin blot 
and Coomassie stain are shown as loading controls. (B) Western blots from 
ESCs differentiated over 10 days. Actin serves as a loading control. (C) 
Representative images of EOS-EGFP positive/OSK-mCherry negative iPSCs at 
reprogramming Day 30, 10 days after dox removal (left) and an iPSC line derived 
from a single colony (right). Scale bars = 400µm. (D) Representative AP staining 
of iPSCs at reprogramming Day 31. (E) Western blots from primary MEFs 
reprogrammed to iPSCs.	 	
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Figure 2.5: Methylation of the Mbd3c promoter during differentiation 
(A) Schematic of the Mbd3 gene showing the sequence and location of the 
Mbd3c promoter CpG island (red bar). Light blue boxes indicate exons. CpGs 
tested for methylation are highlighted in red. (B) Pyrosequencing of bisulfite-
converted DNA from cells collected at the indicated differentiation timepoints. 
Error bars represent the standard deviation of three biological replicates.  
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Mbd3c is dispensable for ESC differentiation 
Mbd3 null ESCs exhibit pluripotency defects and are capable of self-
renewal in the absence of LIF (Kaji et al., 2006). We therefore wanted to test 
whether the MBD3C isoform was specifically required for early stages of 
differentiation. We generated homozygous Mbd3c, Mbd3ab, and Mbd3abc KO 
ESCs (Figure 2.6A) using CRISPR/Cas9 cleavage and error-prone DNA repair 
(Cong et al., 2013). We found that Mbd3c KO ESCs proliferate similarly to 
wildtype (WT) cells. In contrast, Mbd3ab KO and especially Mbd3abc KO ESCs 
grow more slowly than WT (Figures 2.6B and 2.6C), consistent with previous 
observations of Mbd3 null ESCs (Kaji et al., 2006). 
Next, we tested the differentiation capacity of each Mbd3 mutant. 
Consistent with previous studies (Kaji et al., 2006), we found that ESCs lacking 
all MBD3 isoforms (Mbd3abc KO) maintained expression of both OCT4 and 
NANOG over 9 days in media without LIF (Figure 2.6D). Unlike Mbd3abc KOs, 
Mbd3c KOs did not show a noticeable differentiation defect (Figure 2.6E). ESCs 
expressing only Mbd3c (Mbd3ab KO) were largely defective in differentiation 
(although OCT4 and NANOG levels appeared slightly reduced relative to 
Mbd3abc KO lines). Since Mbd3c expression is lost early during differentiation 
(Figures 2.4B and 2.6D), Mbd3ab mutants are functionally equivalent to 
Mbd3abc mutants at mid-to-late differentiation time points, potentially accounting 
for this phenotype. We next asked whether constitutive overexpression of Mbd3c 
in the absence of MBD3A and MBD3B could allow for normal differentiation. To 
test this possibility, we replaced the entire Mbd3 gene with an H3F-tagged 
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Mbd3c transgene overexpressed from the CAG promoter, which is not silenced 
during differentiation. Differentiation proceeds normally in these cells (Figure 
2.7A, top panel), revealing MBD3C can compensate for MBD3A and MBD3B 
when it is overexpressed. Unexpectedly, ESCs overexpressing Mbd3cΔN were 
also able to differentiate (Figure 2.7A, bottom panel), in marked contrast with 
cells expressing Mbd3cΔN at endogenous levels (Figure 2.7B). We conclude that 
Mbd3c is not required for differentiation but can substitute for Mbd3a and Mbd3b 
when overexpressed.  
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Figure 2.6: MBD3C is dispensable for ESC differentiation 
 
(A) Western blot of MBD3 expression in Mbd3 isoform KO ESCs generated 
through CRISPR/Cas9. (B-C) Growth curves for Mbd3c KO (B) and Mbd3ab and 
Mbd3abc KO (C) ESC lines, relative to wildtype (WT) ESCs. Error bars represent 
+/- standard deviation of three replicate experiments performed on each clonal 
replicate. (D-E) Western blots of differentiating Mbd3ab and Mbd3abc KO cells 
(D) and two clonal Mbd3c KO lines (E). 	 	
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Figure 2.7: MBD3C and MBD3CΔN overexpression is suffcient for ESC 
differentiation 
(A) Western blots of indicated proteins during differentiation of WT, Mbd3abc KO 
ESCs overexpressing Mbd3c-H3F, or Mbd3abc KO ESCs overexpressing 
Mbd3cΔN-H3F. (B) Western blots of indicated proteins during differentiation of 
WT or Mbd3cΔN–ab KO ESCs. 
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MBD3 isoforms function redundantly in gene regulation 
Although it is dispensable for differentiation, MBD3C binds chromatin 
(Figure 2.8) and could still be important for regulation of a subset of MBD3 target 
genes independently of the other MBD3 isoforms. To test this possibility, we 
analyzed the transcriptomes of Mbd3 isoform-specific mutant ESCs by RNA-seq. 
Gene expression in Mbd3c KO ESCs was largely normal (Figure 2.9A, left 
panel), with expression of only 38 genes changed more than two-fold compared 
to WT. Similarly, we observed relatively few genes (258) misregulated in Mbd3ab 
KO ESCs that express only Mbd3c (Figure 2.9A, right panel) compared with a 
much larger number (4,879) misregulated in ESCs where all Mbd3 isoforms are 
deleted (Figure 2.9B, left panel and Figure 2.9C). These data suggest that 
Mbd3c can largely compensate for the loss of Mbd3a and Mbd3b at shared 
target genes. 
To test whether the unique 50–amino acid MBD3C N-terminus (and thus 
the interaction with WDR5) is important for this compensatory effect, we also 
performed RNA-seq on ESCs lacking MBD3A and B and the N-terminus of 
MBD3C (Mbd3cΔN−ab KO). In contrast to the relatively few genes misregulated 
in Mbd3ab KO and Mbd3c KO cells, we observed 2,431 genes misregulated in 
Mbd3cΔN−ab KO cells, with nearly twice as many genes upregulated as 
downregulated (1,577 vs. 854 respectively; Figure 2.9B, right panel). The vast 
majority (~93%) of misregulated genes overlapped with genes misregulated in 
Mbd3abc KO cells (Figure 2.9D), indicating that the MBD3C N-terminus is largely 
required for MBD3C to compensate for loss of MBD3A and B. However, as 
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Mbd3abc KO has a stronger phenotype than Mbd3cΔN−ab KO, MBD3C/NuRD 
may also regulate some genes independently of its N-terminal domain. Closer 
examination of the 2,627 genes misregulated only in Mbd3abc KO ESCs (Figure 
2.9D) revealed similar, but weaker misregulation in Mbd3cΔN−ab KO cells in 
most cases that fell below our two-fold cutoff. These data suggest that the 
Mbd3cΔN mutation is not a complete null and are consistent with our finding that 
MBD3CΔN can compensate for loss of MBD3A and MBD3B during ESC 
differentiation, but only when overexpressed (Figure 2.7A and B). 
WDR5 is a component of multiple complexes with key regulatory functions 
in ESCs (Ang et al., 2011; Chelmicki et al., 2014; Li et al., 2012; Ravens et al., 
2014). Wdr5 KD results in loss of ESC self-renewal (Ang et al., 2011), precluding 
the use of Wdr5 KO ESCs to compare the functions of MBD3C and WDR5 in 
gene regulation. However, to test whether the genes misregulated in Mbd3c 
mutant cells are targets of WDR5 and/or WDR5-associated complexes, we 
examined published ESC ChIP-seq data for WDR5 and the MSL/NSL subunit 
MOF (Ang et al., 2011; Li et al., 2012). We observed considerably higher WDR5 
binding at the promoter-proximal regions of genes that were misregulated in 
Mbd3abc KO and Mbd3cΔN−ab KO cells compared to genes that were 
unaffected by Mbd3 mutations (Figure 2.9E), consistent with a regulatory role for 
WDR5 at MBD3 target genes. However, it is likely that WDR5 regulates some of 
these genes through mechanisms independent of MBD3C/NuRD, as we also 
observed higher MOF binding at genes misregulated in Mbd3abc KO and 
Mbd3cΔN−ab KO cells (Figure 2.9F). Similarly, we found that WDR5 binding is 
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enriched at promoter-distal DNase I hypersensitive sites (DHSs) that are co-
bound by MBD3 (Figure 2.9G), suggesting that WDR5 and MBD3 co-regulate 
target gene expression at both promoter-distal enhancers and promoters.  
We have identified a variant ESC-specific NuRD complex that includes the 
histone H3 binding protein WDR5. While WDR5 contributes to H3K4 
trimethlyation by the SET/MLL complex (Ang et al., 2011; Yang et al., 2014) our 
data suggest that a WDR5-binding MBD3C/NuRD complex functions separately 
from SET/MLL. Consistent with these findings, we showed that MBD3C interacts 
with WDR5 at the same binding surface as MLL1 and histone H3, using a 
conserved arginine-containing motif (Couture et al., 2006; Patel et al., 2008). As 
MBD3/NuRD has previously been shown to repress pluripotency genes during 
differentiation (Reynolds et al., 2012), it is possible that MBD3C/NuRD functions 
to oppose SET/MLL activity. 
Our data reveal an additional layer of complexity to the composition and 
function of chromatin remodelers in ESCs and uncover a previously unidentified 
function for the WDR5 protein. The WDR5 binding domain appears to be 
essential for MBD3C/NuRD function in ESCs, while other MBD3/NuRD 
complexes are recruited to the same target genes via the MBD or other binding 
domains. However, since the differentiation defect of Mbd3ab KO cells can be 
overcome by constitutive overexpression of Mbd3cΔN, WDR5 may simply 
enhance the chromatin binding or remodeling activities of MBD3C/NuRD. 
Multiple independent mechanisms likely target different NuRD complexes to 
overlapping targets on chromatin, where the complexes function redundantly. 
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Figure 2.8: MBD3 isoforms associate with chromatin in ESCs 
Western blot of MBD3 from salt fractionation of chromatin from WT ESC nuclei. 
Protein released at indicated concentrations of NaCl is shown. RNA Pol II is 
included as a control. 
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Figure 2.9: MBD3C is redundant with MBD3A and MBD3B in regulation of 
gene expression 
 
(A-B) MA plots showing log2fold change in gene expression in Mbd3c KO ((A), 
left), Mbd3ab KO ((A), right), Mbd3abc KO ((B), left), and Mbd3cΔN−ab KO ((B), 
right) ESCs relative to WT. Genes shown are significantly misregulated ≥ 2-fold 
(adjusted p < 0.05) compared with WT. (C-D). Venn diagrams showing overlap 
between misregulated genes in ESCs of indicated genotypes. (E-F) WDR5 
binding (Ang et al., 2011) (E) and MOF binding (Li et al., 2012) (F) averaged over 
transcription start sites (TSSs) of misregulated or unchanged genes in Mbd3abc 
KO (red) and Mbd3cΔN−ab KO ESCs (purple). (G) Average WDR5 binding over 
MBD3-bound (Yildirim et al., 2011), TSS-distal DNase I hypersensitive sites 
(GSM1014514).  	 	
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MATERIALS AND METHODS 
Cell Culture and Generation of ESC lines 
Murine ESCs are derived from E14 and cultured on gelatin-coated plates as 
previously described (Chen et al., 2013b). Mbd3a-H3F, Mbd3c-H3F, and 
Mbd3cΔN-H3F ESCs were generated by infection of E14 with pLJM1 lentiviral 
vectors carrying the respective constructs.  
 The H3F-WDR5 targeting construct was made by inserting PCR-produced 
homology arms (959 and 561 bp) and an H3F tag into pBluescript II SK+ 
(Stratagene). Oligos were inserted into pX330-puroR to target to the N-terminus 
of WDR5. The plasmids were transfected with FuGENE HD (Promega) into E14, 
Mbd3c KO, and Mbd3abc KO cells. Clones were selected with puromycin and 
screened by PCR, sequencing, and western blot. 
 
Expression of MBD3C and WDR5 domain mapping mutants 
MBD3C-H3F, V5-WDR5 constructs and the indicated WDR5 mutants (Yang et 
al., 2014) were cloned into pCAGGS-IRES-HygroR using the 5’ XhoI site and the 
3’ EcoRI site. pCAGGS-V5-WDR5 was created from a synthesized full-length 
mouse Wdr5. MBD3A-H3F and truncations of MBD3C-H3F with XhoI and MfeI 
restriction sites were derived by PCR on Mbd3-H3F sequences and cloned into 
the vector. The MBD3C Δ41-50 and R43A mutant constructs were made by PCR 
on pCAGGS-MBD3C-H3F with primers incorporating the mutations and flanking 
primers and then digesting the new sequences and ligating them into the vector. 
pCAGGS–cN41-50–MBD3A-H3F was made by synthesizing the N-terminus and 
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inserting it into the MBD3A plasmid using the XhoI site and a gene-internal 
BamHI site. Plasmids were transiently transfected into 293T cells using FuGENE 
HD (Promega), and the cells were harvested for IP after 2 days. 
 
Generation of MBD3 isoform KO ESCs 
Mbd3ab, Mbd3c, Mbd3abc, and Mbd3cΔN-ab KO ESC lines were generated 
using the CRISPR/Cas9 system (Cong et al., 2013) to introduce mutations into 
Mbd3 exon 2 (Mbd3ab KO and Mbd3cΔN−ab KO), intron 2 (Mbd3c KO), or exon 
5 (Mbd3abc KO). Guide RNAs targeting Mbd3ab, Mbd3c, or Mbd3abc (see Table 
2.3 for sequences) were cloned into the pX330-puroR vector and transfected into 
E14 ESCs as described (Hainer et al., 2015). Individual clones were screened by 
TOPO cloning (Invitrogen) and sequencing to verify the presence of homozygous 
frameshift mutations. ESC lines were further screened by western blot to verify 
loss of the appropriate MBD3 isoform(s). To create the Mbd3cΔN−ab KO line, we 
first transfected the pX330 plasmid targeting Mbd3c into E14 ESCs along with a 
donor plasmid containing the Mbd3c coding sequence with a 50-amino acid N-
terminal deletion. The donor plasmid was generated by annealing oligos to make 
the Mbd3cΔN cDNA construct and cloning along with ~2kb homology arms 
flanking the Mbd3c start site into pBluescript SK II+ (Stratagene). Verified 
Mbd3cΔN ESC lines were then retargeted using the Mbd3ab KO guide RNA 
plasmid and screened as described above. 
Mbd3abc KO/Mbd3c o/e ESC lines were made by replacing the 
endogenous Mbd3 locus with a construct containing PCR-produced homology 
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arms (2070 and 1649 bp), the full CAGGS promoter, and a modified Mbd3c-H3F-
polyA sequence without CpGs in the gene or tag. The Mbd3abc KO – cΔN o/e 
construct was made using PCR and restriction digestion to delete the 150 bp 
corresponding to the unique N-terminus of MBD3C. Oligos were inserted into two 
CRISPR plasmids (pX330-puroR) and transfected into E14 cells as described 
above. Clones were selected with puromycin and screened by PCR, sequencing, 
and western blot. 
 
5’RACE 
5’RACE was performed on 4µg total RNA using the 5’RACE System Version 2.0 
kit (Invitrogen). See Table 2.3 for primer sequences. 
 
MBD3 Purification, WDR5 Purification, and LC-MS/MS 
MBD3/NuRD complex was purified from MBD3-H3F, MBD3A-H3F, MBD3C-H3F, 
and MBD3CΔN-H3F ESCs as described (Yildirim et al., 2011). Purified samples 
were separated by SDS-PAGE, stained with SimplyBlue SafeStain (Invitrogen), 
and LC-MS/MS was performed as described in (Chen et al., 2013b). For WDR5 
complex purification, nuclear fractions were isolated from H3F-WDR5 ESCs 
using the NE-PER kit (Thermo), diluted 1:3 in MVL buffer (50mM Tris, pH 7.5; 
250mM NaCl; 0.1% Triton X-100), and purified similarly, omitting the His 
purification step.   
 
Western Blotting and Immunoprecipitation 
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Western blots were performed with the following antibodies: anti-MBD3 (Bethyl 
A302-528A and Abgent AM2203B), anti-FLAG (M2, Sigma F1804), anti-WDR5 
(Bethyl A302-429A and A302-430A), anti-OCT4 (Santa Cruz sc-8628), anti-
NANOG (Bethyl A300-398A), anti-MTA1 (Bethyl A300-911A), anti-MTA2 (Santa 
Cruz sc-28731), anti-CHD4 (Bethyl A301-082A) anti–β-ACTIN (Sigma A1978), 
anti–RNA POLYMERASE II (Santa Cruz sc-899), anti-RBBP4 (Bethyl A301-
206A), anti-RBBP7 (Bethyl A300-958A), anti-LSD1 (Bethyl A300-215A), anti-
p66α (Bethyl A302-358A), anti-p66β (Bethyl A301-281A), anti-HDAC1 (Bethyl 
A300-713A), anti-HDAC2 (Bethyl A300-705A), anti-ASH2L (Bethyl A300-112A), 
anti-V5 (Invitrogen 46-0705). Mouse tissue lysates were prepared by 
homogenizing indicated tissues in lysis buffer (50mM Tris-HCl pH 7.5; 150mM 
NaCl; 0.5% Triton X-100; 5% glycerol; 1mM PMSF). For IP, nuclear lysates were 
prepared using the NE-PER kit (Thermo). FLAG IP was performed as described 
in (Chen et al., 2013b). MBD3 IPs in ESCs and 293T cells were performed 
similarly, except washes were performed in MVL buffer + 1mM EDTA. 
 
Glycerol Gradient Analysis 
Nuclear extracts were prepared from Mbd3-H3F ESCs using the NE-PER kit 
(Thermo). Nuclear extract (1470µg) was diluted in MVL buffer and spun in a 10-
40% glycerol gradient at 37krpm for 17 hours in a Beckmann L-90K 
ultracentrifuge. 29 fractions were collected and odd fractions western blotted with 
the indicated antibodies. 
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Embryoid Body Differentiation 
ESCs were differentiated to embryoid bodies (EBs) in suspension culture. 2.5 x 
106 cells were plated in ESC medium without LIF in bacteriological plates. Cells 
were replated to non-gelatinized cell culture plates after 3 days and harvested for 
western blots at the indicated timepoints. 
 
Chromatin Extraction Assay 
Chromatin was extracted from WT ESCs by salt fractionation as described 
(Henikoff et al., 2009). Briefly, 4 x 107 cells were pelleted, washed in PBS, and 
resuspended in TM2 buffer (10mM Tris-HCl pH 7.5, 2mM MgCl2, 1.5% NP-40, 1x 
HALT protease inhibitor cocktail) on ice for 5min. Cells were pelleted and the 
nuclei incubated in TM2 + 70mM NaCl for 2h at 4°C. Nuclei were pelleted and 
incubated as before in TM2 + 140mM NaCl, and further pelleted and incubated in 
TM2 + 600mM NaCl overnight at 4°C. Supernatants from each incubation were 
saved as 0, 70,140 and 600mM NaCl fractions, clarified by centrifugation at full 
speed, and western blotted with the indicated antibodies. 
 
Reprogramming to pluripotent stem cells 
Lentiviral plasmids for dox-inducible Oct4, Sox2, and Klf4 expression (pLenti-Tet-
OSK-mCherry) and for L-Myc expression (pLenti-Tet-L-Myc) were generated by 
digestion of CMV-OSK and CMV-L-Myc cDNA from FUW-OSKM and pMXs-Ms-
L-Myc (Addgene 20328 and 26023 respectively) and cloning into pcDNA3.1 with 
HIV1-based 5’ and 3’ LTRs from pGIPZ. To package lentivirus, 293T cells were 
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transfected with 5µg pLenti-Tet-OSK-mCherry, pLenti-Tet-L-Myc, FUW-rTtA 
(Addgene 20342), or EOS-EGFP (Addgene 21313) lentiviral reporter plasmids 
along with packaging plasmids (5µg psPAX2 and 2.5µg pCMV-VSV-G 
(Addgene)). Primary MEFs were infected with day 2 viral supernatant using 
8µg/mL hexadimethrine bromide (Sigma), and re-infected after 24 hours. MEFs 
were replated in ESC media after 48 hours and induced with 2µg/ml dox 4 days 
after the first infection. Dox was removed at day 20 and cells were cultured for an 
additional 10 days. On Day 30 cells were imaged to assess loss of OSK 
transgenes and EOS-EGFP reporter activation, and on day 31 were stained for 
alkaline phosphatase according to kit instructions (Millipore). Single colonies 
were picked on Day 30, expanded, and western blotted with the indicated 
antibodies. Media were changed every other day. 
 
Bisulfite pyrosequencing 
WT ESCs were subjected to embryoid body differentiation and harvested at the 
indicated timepoints. Briefly, genomic DNA was phenol-chloroform extracted from 
cells incubated in ES cell lysis buffer (10 mM Tris, pH 7.5; 10 mM EDTA; 10 mM 
NaCl; 0.5% sarkosyl) with 1 µg/µL proteinase K at 55°C overnight. The DNA was 
bisulfite converted using the EpiTect Bisulfite Kit (QIAGEN). Primers were 
designed for the Mbd3c CpG island using PyroMark Q24 software (QIAGEN, see 
Table 2.3 for sequences), with one PCR primer in a pair biotinylated, and PCR 
was performed on the converted DNA with KAPA HiFi HotStart Uracil+ ReadyMix 
(Kapa Biosystems). PCR products were bound to streptavidin sepharose beads 
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(GE Healthcare) and sequenced using a PyroMark Q24 (QIAGEN). Data were 
analyzed using PyroMark Q24 software. 
 
RNA-seq 
Total RNA was isolated from two biological replicate WT, Mbd3ab KO, Mbd3c 
KO, Mbd3abc KO, and Mbd3cΔN−ab KO ESC lines using TRIzol (Life 
Technologies), and purified with the Zymo RNA Clean and Concentrator kit. 2µg 
RNA was used for library preparation. RNA was rRNA-depleted (NEB and 
Clontech) and strand-specific libraries were prepared using the TruSeq Stranded 
mRNA LT kit (Illumina) by Applied Biological Materials, Inc. 
 
RNA-seq data analysis 
Reads were mapped to the mouse mm10 genome with TopHat2 (Kim et al., 
2013), using parameters --library-type fr-firststrand --segment-length 38. Mapped 
reads were processed in HOMER (Heinz et al., 2010) using the 
“analyzeRepeats” command to calculate raw counts and normalized reads per 
kilobase per million mapped reads (rpkm) for each gene. Differential gene 
expression was calculated with DESeq2 (Love et al., 2014) using the 
“getDiffExpression” command in HOMER. Genes with an adjusted p value < 0.05 
and log2 (fold change) were considered significantly changed. 
To map WDR5 and Mof binding at TSSs of significantly changed genes, 
WDR5 (Ang et al., 2011) and Mof (Li et al., 2012) ChIP-seq data were 
downloaded from GEO (GSE22934 and GSE37268) and aligned to the mouse 
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mm10 genome using Bowtie (Langmead et al., 2009). Mapped reads were 
processed in HOMER using the “annotatePeaks” command. For Mof ChIP-seq, 2 
replicate libraries were averaged in the aggregation plot. 
To map WDR5 at MBD3-bound DNase I hypersensitive sites (DHSs), 
peaks were called from MBD3 ChIP-seq data (Yildirim et al., 2011); GSE31690) 
using the HOMER “findPeaks” command, and MBD3-bound DHSs were 
identified using the “mergePeaks” command with peaks called from mouse 
ENCODE DHSs (GSM1014154) without TSSs. The WDR5 ChIP-seq library was 
aligned to the MBD3-bound DHS peak data using the “annotatePeaks” 
command.  
 
ACCESSION NUMBERS 
RNA-seq data was deposited at GEO with accession # GSE80708. 
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Table 2.3: Oligonucleotides used in Chapter II 
 
Name Sequence Purpose 
Mbd3c-10trunc-
XhoI-f 
CTCGAGACCATGATCTCCGTGCCTGATCGC clone Mbd3cΔ1-10-FLAG 
into pCAGGS 
Mbd3c-20trunc-
XhoI-f 
CTCGAGACCATGATTCAGGCTCTGGCTAAGCAC clone Mbd3cΔ1-20-FLAG 
into pCAGGS 
Mbd3c-30trunc-
XhoI-f 
CTCGAGACCATGCCCTCCAACCCTCCATGGAC clone Mbd3cΔ1-30-FLAG 
into pCAGGS 
Mbd3c-40trunc-
XhoI-f 
CTCGAGACCATGGCGGCCCGCTGCAGA clone Mbd3cΔ1-40-FLAG 
into pCAGGS 
XhoI-Mbd3ab-f CTCGAGACCATGGAGCGGAAGAGGTGG clone Mbd3a-FLAG into 
pCAGGS 
3xFLAG-MfeI-r CAATTGCTACTTGTCATCGTCATCCTTG clone Mbd3a/c-FLAG 
sequences into pCAGGS 
pCAGGS-
insertseq-f 
GCAACGTGCTGGTTATTGTGC mutagenesis PCR on 
pCAGGS-Mbd3c-FLAG 
Mbd3 seq9 R CCACACACCAGGGTTCTTCT mutagenesis PCR on 
pCAGGS-Mbd3c-FLAG 
Mbd3c-R43A-r GAAGACTCTGCAGGCGGCCGCTCCGACC R43A mutagenesis on 
pCAGGS-Mbd3c-FLAG 
Mbd3c-
41del50-r 
CAGGCTTGCCTCCGACCGGGGTCC Δ41-50 mutagenesis on 
pCAGGS-Mbd3c-FLAG 
XhoI-V5-
BamHI+ 
AGCTTCTCGAGACCATGGGTAAGCCTATCCCTAACCCTCTCCTCGG
TCTCGATTCTACGGGATCCGCCAC 
clone V5 tag into 
pCAGGS-Wdr5 (replaces 
GST tag) 
XhoI-V5-
BamHI- 
GTGGCGGATCCCGTAGAATCGAGACCGAGGAGAGGGTTAGGGATA
GGCTTACCCATGGTCTCGAGAAGCT 
clone V5 tag into 
pCAGGS-Wdr5 (replaces 
GST tag) 
Mbd3a_pLJM1
AfeI 
AGCGCTACCATGGAGCGGAAGAGGTG clone Mbd3a-H3F into 
pLJM1 
Mbd3c_pLJM1
AfeI 
AGCGCTACCATGGCGCGCATTTGGTTTG clone Mbd3c-H3F into 
pLJM1 
Mbd3ctrunc_pL
JM1AfeI 
AGCGCTACCATGGGCAAGCCTGACCTGAA clone Mbd3cΔN-H3F into 
pLJM1 
Mbd3FLAG_pL
JM1BstBI 
TTCGAACTACTTGTCATCGTCATCCTTG clone Mbd3-H3F into 
pLJM1 
Mbd3a_NotIEco
RI 
AAGCGGCCGCACCATGGAGCGGAAGAGGTGGGAGTGC Amplify Mbd3a from 
cDNA 
Mbd3a/b/c R CGGAATTCCACTCGCTCTGGCTCCGGCTTTCCTCCTC Amplify Mbd3 (all 
isoforms) from cDNA 
Mbd3c v2 F AAGCGGCCGCACCATGGCGCGCATTTGGTTTGGTGGG Amplify Mbd3c from cDNA 
Mbd3c v2 dN AAGCGGCCGCACCATGGGCAAGCCTGACCTGAACACC Amplify Mbd3cΔN from 
cDNA 
GSP1-3 TCCTGACCAGTTCTTCT 5'RACE sequencing 
primer 
GSP1-2 GTGTAGAGCACTCGCAATG 5'RACE sequencing 
primer 
Mbd3c Xho1 CTCGAGACCATGGCGCGCATTTGGTTTG clone Mbd3c-H3F into 
pCAGGS 
Mbd3ctrunc 
Xho1 
CTCGAGACCATGGGCAAGCCTGACCTGAA clone Mbd3cΔN-H3F into 
pCAGGS 
Mbd3FLAG 
EcoR1 
GAATTCCTACTTGTCATCGTCATCCTTG clone Mbd3c- and 
Mbd3cΔN-H3F into 
pCAGGS 
FLAG Xho1 CTCGAGACCATGGACTACAAAGACGATGA clone FLAG-Wdr5 domain 
muts into pCAGGS 
hWdr5 EcoR1 GAATTCTTATTAGCAGTCACTCTTCCACA clone FLAG-Wdr5 domain 
muts into pCAGGS 
pX330-
Mbd3abc-1 
CACCGGTGTGTAGAGCACTCGCAA Mbd3abc KO guide RNA 
oligo 
pX330-
Mbd3abc-2 
AAACTTGCGAGTGCTCTACACACC Mbd3abc KO guide RNA 
oligo 
pX330-Mbd3ab-
1 
CACCGCTTTCCGGTGCGGAAGTCGA Mbd3ab KO guide RNA 
oligo 
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pX330-Mbd3ab-
2 
AAACTCGACTTCCGCACCGGAAAGC Mbd3ab KO guide RNA 
oligo 
pX330-Mbd3c-1 CACCGTCCATGGACCCCGGTCGGAG Mbd3c KO guide RNA 
oligo 
pX330-Mbd3c-2 AAACCTCCGACCGGGGTCCATGGAC Mbd3c KO guide RNA 
oligo 
Mbd3abcCRISP
R seq F 
GACTTACAGGGAGTTGTGAGCC PCR Mbd3abc KO from 
gDNA to verify sequence 
Mbd3abcCRISP
R seq R 
TGCTTTCTCACTGCTATTTCCCCA  PCR Mbd3abc KO from 
gDNA to verify sequence 
Mbd3abCRISP
R seq F 
CCTTAGGCTTCCCAGATGAACT PCR Mbd3ab KO from 
gDNA to verify sequence 
Mbd3abCRISP
R seq R 
GGTGCTTAGCCAGAGCCTGAA PCR Mbd3ab KO from 
gDNA to verify sequence 
Mbd3cCRISPR 
seq F 
GAAGAAGTTCCGCAGCAAGC PCR Mbd3c KO from 
gDNA to verify sequence 
Mbd3cCRISPR 
seq R 
AGGCAATGGTTTCTTCCACCC  PCR Mbd3c KO from 
gDNA to verify sequence 
Mbd3ctrunc 
Sal1 
TCGACATGGGCAAGCCTGACCTGAACACCGCGCTGCCTGTACGGC
AGACTGCATCCATCTTCAAGCAA 
Annealing oligo to clone 
Mbd3cΔN into pBluScript 
for CRISPR 
Mbd3ctrunc 
Age1 
CCGGTTGCTTGAAGATGGATGCAGTCTGCCGTACAGGCAGCGCGG
TGTTCAGGTCAGGCTTGCCCATG 
Annealing oligo to clone 
Mbd3cΔN into pBluScript 
for CRISPR 
Mbdc BS+ AGGGAGGTGTTTAGTTAGAGT PCR bisulfite-converted 
gDNA from Mbd3c CpG 
island 
Mbd3c BS- [Btn]AAAAAAAATTCCCCAACAAACCACAACT PCR bisulfite-converted 
gDNA from Mbd3c CpG 
island. Adds biotin tag 
Mbd3c-1_BS+ ATTTTTATTTTGATTTGGTTGGAAGAATTA PCR bisulfite-converted 
gDNA from Mbd3c CpG 
island 
Mbd3c-1_BS- [Btn]CTTCCCACCTACCTTCCTAATAACCTA PCR bisulfite-converted 
gDNA from Mbd3c CpG 
island. Adds biotin tag 
Mbd3c_BSseq GATTTTTTATTTATTAAATTAAATG Pyrosequencing primer #1 
Mbd3c-
1b_BSseq 
GTGTTAGTTGTGGTTTG Pyrosequencing primer #2 
EcoRI-5'-Wdr5-f TTGAATTCCTTGGGACAGTTGATTTGTTGGAGG clone H3F-Wdr5 5' 
homology arm 
BamHI-5'-Wdr5-
r-PAMmut 
AAGGATCCCATGGCTCTGAAGACCACAGGGC clone H3F-Wdr5 5' 
homology arm 
XbaI-3'-Wdr5-f AATCTAGAGCCACAGAGGAGAAGAAGCCA clone H3F-Wdr5 3' 
homology arm 
SacI-3'-Wdr5-r TAGAGCTCATCAAGCACTAGCTGGTTCCAAAC clone H3F-Wdr5 3' 
homology arm 
BamHI-6xHis-f TAGGATCCCATCACCACCATCATCACGC clone 6xHis,3xFLAG tag 
for H3F-Wdr5 
XbaI-3xFLAG-r TTTCTAGACTTGTCATCGTCATCCTTGTAGTC clone 6xHis,3xFLAG tag 
for H3F-Wdr5 
pX330-Wdr5-
Nterm+ 
CACCGTTCACGGTGTCCTGCCCTGT CRISPR oligo targeting 
the N terminus of Wdr5 
pX330-Wdr5-
Nterm- 
AAACACAGGGCAGGACACCGTGAAC CRISPR oligo targeting 
the N terminus of Wdr5 
XhoI-5'Mbd3-
homol-f 
CTCGAGTCCTGCATACGTCTCTTCCCAG clone Mbd3abc 
KO/Mbd3c o/e 5' 
homology arm 
SalI-5'Mbd3-
homol-r 
GTCGACACGTGGTAGACTTTCTGCC clone Mbd3abc 
KO/Mbd3c c o/e 5' 
homology arm 
EcoRI-3'Mbd3-
homol-f 
GAATTCTGCTGCAGGCCAGGGTGG clone Mbd3abc 
KO/Mbd3c o/e 3' 
homology arm 
BamHI-3'Mbd3-
homol-r 
GGATCCTACCTCTGGTGCCACCATCCT clone Mbd3abc 
KO/Mbd3c o/e 3' 
homology arm 
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pCAGGS-5'seq GAGCCTCTGCTAACCATGTTCA mutagenesis PCR on 
Mbd3abc KO/Mbd3c o/e 
construct 
Mbd3c-noCpG-
afterBsrGI-r 
AGAGCACTGGCAATGGCAGA mutagenesis PCR on 
Mbd3abc KO/Mbd3c o/e 
construct 
Mbd3c-noCpG-
50trunc-r 
CAGGTCAGGCTTGCCCATGGTGGCAAGCT Δ1-50 mutagenesis on 
Mbd3abc KO/Mbd3c o/e 
construct 
pX330-5'Mbd3+ CACCGAGAAAGCAGAACCTTACACG CRISPR oligo targeting 5' 
of the Mbd3 locus 
pX330-5'Mbd3− AAACCGTGTAAGGTTCTGCTTTCTC CRISPR oligo targeting 5' 
of the Mbd3 locus 
pX330-3'Mbd3+ CACCGAGCCAGAGCGAGTGTAGCAC CRISPR oligo targeting 5' 
of the Mbd3 locus 
pX330-3'Mbd3− AAACGTGCTACACTCGCTCTGGCTC CRISPR oligo targeting 5' 
of the Mbd3 locus 
Mbd3-exon6-f GGAAGCAGGAGGAGCTGGT PCR check primer for 
Mbd3abc KO/Mbd3c o/e 
Mbd3c-noCpG-
outcheck-r 
TGGCCTAGCAACATTCTGGC PCR check primer for 
Mbd3abc KO/Mbd3c o/e 
Mbd3c-noCpG-
outcheck-f 
GATTTCCAGACAGTGTGCACTAAGTG PCR check primer for 
Mbd3abc KO/Mbd3c o/e 
CMVenhancer-r GGCGGGCCATTTACCGTAAG PCR check primer for 
Mbd3abc KO/Mbd3c o/e 
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CHAPTER III: CHARACTERIZATION OF H3.3K56AC IN PLURIPOTENCY 
AND DIFFERENTIATION 
 
Contributions 
Tom Fazzio designed and cloned H3.3K56R guide RNAs and homology arm 
templates and constructed H3.3K56R mutant ESC lines. Unpublished data from 
Feixia Chu is referenced in the Introduction. Ly-sha Ee performed all other 
experiments. Figure 3.1B was made by Kurtis McCannell and used with 
permission. 
 
ABSTRACT 
 Post-translational modifications of histones play numerous roles in the 
modulation of chromatin structure and gene expression. Acetylation of lysine 56 
of histone H3 (H3K56ac) is a modification in the histone core that is well-
characterized and abundant in yeast but less common in mammalian cells, 
where its functions are largely unknown. In ESCs, H3K56ac interacts with OCT4, 
SOX2, and NANOG at gene promoters to maintain pluripotency but the precise 
roles of H3K56ac in ESC pluripotency and during differentiation are still 
undescribed. It is also unclear whether K56ac has separate functions when it 
occurs on different histone H3 variants. In this chapter we show that ESC lines 
depleted for H3.3K56ac by K56R substitution in both H3.3 genes are largely 
unchanged in morphology and self-renewal. However, although loss of 
H3.3K56ac does not appear to be critical to exit the pluripotent state, H3.3K56ac 
is important for differentiation in certain contexts, particularly the formation of 
neurons. Our work complements previous data indicating that H3K56 
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hyperacetylation leads to upregulation of the ectodermal lineage during 
differentiation. 
 
INTRODUCTION 
 Histone modifications regulate chromatin structure by binding and 
recruiting other chromatin regulators that, at genomic regions such as enhancers 
and promoters can in turn activate or repress transcription. In embryonic stem 
cells (ESCs), many histone modifications are linked to the transcription factor 
network that includes the pluripotency factors OCT4, SOX2, and NANOG and 
which is essential to maintain ESCs in an undifferentiated state. Pluripotent 
chromatin is characterized by a dynamic, more open structure as compared with 
somatic cell chromatin (Meshorer and Misteli, 2006). In addition to “bivalent” 
domains – regions co-marked by modifications associated with activation and 
repression (H3K4me3 and H3K27me3 respectively) – ESCs contain elevated 
levels of activation-associated histone marks accompanied by higher global 
transcription (Efroni et al., 2008).  
 While most well-studied modifications are located on the N-terminal 
histone tails, modifications of amino acids within the globular histone fold domain 
have also been identified and characterized. Lysine 56 is located in the α-N helix 
of histone H3 (Figure 3.1A and B) just N-terminal to the histone fold at the entry 
and exit points of DNA (Masumoto et al., 2005; Ozdemir et al., 2005; Xu et al., 
2005). Acetylation of lysine 56 (by the RTT109 and p300 and GCN5 histone 
acetyltransferases in yeast and mammals respectively) disrupts a water-
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mediated contact between the histone and the DNA (Das et al., 2009; Driscoll et 
al., 2007; Han et al., 2007; Luger et al., 1997; Neumann et al., 2009; Schneider 
et al., 2006; Tjeertes et al., 2009) and possibly destabilizes nucleosomes, 
although a recent study reported no change in folding of H3K56Q nucleosomal 
arrays (Watanabe et al., 2010). 
 In yeast H3K56ac is important for histone gene expression through 
recruitment of SWI/SNF, and has numerous roles in CAF1-mediated nucleosome 
assembly, response to DNA damage, DNA repair, and H2A.Z dimer exchange  
(Chen et al., 2008a; Li et al., 2008; Masumoto et al., 2005; Vempati et al., 2010; 
Watanabe et al., 2013; Xu et al., 2005). H3K56ac is far less abundant in 
mammalian cells (about 1% of total H3 in HeLa cells) (Xie et al., 2009) and its 
functions in mammalian cells are largely unknown. In both human and mouse 
ESCs H3K56ac is linked to the pluripotency network, co-localizing with OCT4, 
SOX2, and NANOG at target gene promoters (Tan et al., 2013; Xie et al., 2009). 
Depletion of H3K56ac by knockdown of the histone chaperone Asf1a led to 
decreased expression of pluripotency factors and increased expression of 
markers of all three germ layers (Tan et al., 2013), and Oct4 KD ESCs exhibit a 
marked decrease in H3K56ac levels by mass spec analysis (T. Fazzio and F. 
Chu, unpublished observation) suggesting that H3K56ac is important for ESC 
self-renewal and pluripotency and/or for preventing spontaneous differentiation. 
Additional work from the Grunstein lab in human ESCs showed that H3K56ac 
becomes enriched at developmental gene promoters during RA-induced 
differentiation, although transcription of a subset of enriched genes was 
		
	
87	
unchanged (Xie et al., 2009). A recent study showed that H3K56ac levels in 
ESCs could be regulated by a long noncoding RNA, lncPRESS1, through 
sequestration of the NAD-dependent deacetylase SIRT6 (Jain et al., 2016).  
 Here, we have constructed ESC lines with homozygous K56R mutations 
in each H3.3 gene to deplete K56ac at histone H3.3, which marks active gene 
promoters and enhancers as well as heterochromatic and repeat regions in 
ESCs (Elsässer et al., 2015; Goldberg et al., 2010). We found that ESC self-
renewal is largely unchanged in H3.3K56R mutants. Loss of OCT4 and NANOG 
during differentiation, as well as timely upregulation of many lineage markers 
were similarly unaffected. However, H3.3K56R mutants appear to be defective in 
formation of neurons during retinoic acid- (RA)-induced differentiation, although 
we did not observe decreased or delayed expression of two common 
neuroectoderm markers. Together, our data suggest that H3.3K56ac is important 
to maintain or enhance ESC pluripotency and is also required during later stages 
of differentiation. Our work further indicates that differently-modified histone 
variants could play varied roles in pluripotency and differentiation. 
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Figure 3.1: The mammalian core and replication-independent histone H3 
variants, and position of H3K56 on the nucleosome 
(A) Sequence alignment of the mammalian core (H3.1 and H3.2) and replication-
independent (H3.3) H3 variants. Amino acids that are not conserved in H3.3 are 
shown in red, and differing between H3.1 and H3.2/3 in orange. Lysine 56 is 
indicated in green. (B) Pymol crystal structure of the nucleosome (Luger et al., 
1997; PDB:1AOI) showing the position of both H3K56 residues (magenta). H2A, 
H2B, H3, and H4 are shown in yellow, brown, green, and blue respectively. Used 
with permission from Kurtis McCannell. 
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RESULTS AND DISCUSSION 
 To assess the effects of H3K56ac loss on ESC self-renewal and 
pluripotency we created an ESC line where lysine 56 of both H3.3 alleles was 
homozygously mutated to arginine (henceforth referred to as the H3.3K56R 
mutant) using the CRISPR/Cas9 system (Cong et al., 2013). As both H3.1 and 
H3.2 are expressed from tandem, multicopy clusters at multiple loci (Marzluff et 
al., 2002) we were unable to create H3.1 or H3.2 mutant lines, as we could not 
target every H3.1 or H3.2 gene copy (T. Fazzio, personal communication). In 
contrast, H3.3 is expressed from two discrete genes (H3f3a and H3f3b) with 
different coding sequences, allowing for sequential targeting with two homology 
constructs (see Methods for details). Although H3.3 comprises a minority of total 
H3 in ESCs and the fraction of H3.3 acetylated at K56 is unknown, H3.3 has 
highly distinct genomic localization and functions in ESCs and development 
(Banaszynski et al., 2013; Elsässer et al., 2015; Goldberg et al., 2010; Jang et 
al., 2015). We therefore hypothesized that loss of H3.3K56ac could result in 
similar or overlapping phenotypes as those observed in H3.3-depleted ESCs.  
 
H3.3K56ac is not required for ESC self-renewal 
To determine whether H3K56ac levels were reduced in H3.3K56R 
mutants we prepared histones by acid extraction and western blotted for 
H3K56ac. We observed a very slight decrease in H3K56ac levels in H3.3K56R 
mutants (Figure 3.2A). This result was not unexpected given that K56ac has 
been detected in less than 1% of total H3 (Das et al., 2009; Xie et al., 2009; Yuan 
		
	
90	
et al., 2009). It is however important to note that several antibodies against 
H3K56ac including the Active Motif antibody used in this study were shown to be 
non-specific (Drogaris et al., 2012; Pal et al., 2016). It is therefore likely that the 
blot in Figure 3.2A is skewed by cross-reactivity with H3K9ac and other 
acetylated H3 residues. H3.3K56R ESCs exhibit colony morphology similar to 
wildtype (Figure 3.2B), and unchanged proliferation rates (Figure 3.2C). 
Moreover, H3.3K56R cells do not appear to be defective in self-renewal as 
determined by similar levels of alkaline phosphatase (AP) staining to WT when 
maintained in leukemia inhibitory factor (LIF) (Figure 3.2D). We next tested 
whether H3.3K56R ESCs were defective for differentiation in an embryoid body 
(EB) timecourse. We observed normal rates of OCT4 and NANOG pluripotency 
factor loss during the timecourse (Figure 3.2E, top panel) and similar morphology 
in WT and H3.3K56R cells differentiated for 12 days (Figure 3.2E, bottom panel), 
consistent with a flattening out and loss of AP staining in H3.3K56R ESCs 
cultured for 3-5 days in the absence of LIF (Figure 3.2D). Together, these data 
indicate that H3.3K56ac is not required for ESC self-renewal or for mediating loss 
of pluripotency factors during differentiation. Interestingly, a previous study 
showed that OCT4, SOX2, and NANOG expression is upregulated in Sirt6 KO 
ESCs and stabilized during Sirt6 KO EB differentiation (Etchegaray et al., 2015). 
SIRT6 is an NAD-dependent Class III histone deacetylase that deacetylates 
H3K9 and H3K56, among other H3 lysine residues (Michishita et al., 2008; 2009; 
Yang et al., 2009). Thus, H3K56 hyperacetylation appears to block differentiation 
by preventing loss of pluripotency factors. Additionally, Etchegaray et al. showed 
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that expression of endoderm and mesoderm lineage markers was downregulated 
while expression of ectoderm markers was upregulated with respect to wildtype 
in Sirt6 KO EBs. To further investigate the role of H3K56ac in differentiation we 
are currently constructing an H3.3K56Q mutant ESC line. As the K56Q mutation 
mimics constitutive H3K56 acetylation (Masumoto et al., 2005) we hypothesize 
that this mutant will behave similarly to the Sirt6 KO in differentiation assays. The 
H3.3K56Q cell line will also allow us to distinguish H3K56ac-specific phenotypes 
from those resulting from H3K9 hyperacetylation that are observed in the Sirt6 
KO. 
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Figure 3.2: H3.3K56R ESCs exhibit normal morphology, growth, and EB 
differentiation 
(A) Western blot of acid-extracted histones from the indicated ESC lines. H3 
serves as a loading control. (B) Representative images of WT and H3.3K56R 
mutant ESCs. (C) Growth curve for H3.3K56R ESC lines, relative to WT ESCs. 
(D) Histogram of AP staining of WT and H3.3K56R ESCs at the indicated 
timepoints in the presence or absence of LIF. The number of scored colonies for 
each sample is indicated above the corresponding bar. Representative images 
for scored classes are shown. (E) Western blots of differentiating WT and 
H3.3K56R ESCs (top) and representative images of WT and H3.3K56R ESCs at 
differentiation day 12 (bottom). 
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Differentiating H3.3K56R cells are defective for some mesoderm and 
endoderm lineage markers 
 To further investigate pluripotency of the H3.3K56R ESCs, we measured 
expression levels of markers from the three germ layers using RT-qPCR. 
Consistent with the western blots in Figure 3.2E, Oct4 and Nanog RNA levels 
decreased in WT and H3.3K56R ESCs during EB differentiation (Figure 3.3A). 
We first examined expression of markers for mesoderm, the central embryonic 
germ layer that gives rise to most blood cells, heart and muscle tissue. Cardiac 
specification can be divided into several stages of mesoderm differentiation, each 
of which is marked by the presence of specific genes (Rajala et al., 2011; 
Wamstad et al., 2012). As we had observed beating cardiomyocytes in late-stage 
differentiating H3.3K56R cultures, we predicted that cardiac genes would be 
largely unchanged. Expression and kinetics of early cardiac mesoderm genes 
were largely unchanged in the H3.3K56R mutant, save for a very slight decrease 
in Flk1 (Figure 3.3B). Expression of two cardiac progenitor markers, Nkx2-5 and 
Gata4 was also slightly reduced, although there was no delay in upregulation 
(Figure 3.3C). Interestingly, the expression of the mature cardiomyocyte markers 
Myl7 and Tnnt2 was highly downregulated in H3.3K56R (Figure 3.3D), raising the 
possibility that the H3.3K56R mutants are less efficient in generating beating 
cardiomyocytes than WT. Since EBs produce cells from multiple differentiated 
lineages, we next performed directed differentiation (Kattman et al., 2011; 
Wamstad et al., 2012) to better enrich for cardiomyocytes and possibly quantify 
the differences in efficiency. Surprisingly, despite downregulation of Brachyury 
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the expression of the cardiac progenitor Tbx5 and the cardiomyocyte markers 
Myl7 and Tnnt2 were all upregulated in the H3.3K56 mutant (Figure 3.3E), 
suggesting no defect in cardiac differentiation. Although further experimental 
replicates will be necessary to confirm this result, these data suggest that while 
loss of H3.3K56ac leads to mis-regulation of some mesodermal markers, 
acetylation is not required to form functional cardiac progenitors and 
cardiomyocytes, particularly if formation of cardiac mesoderm is enriched using a 
directed differentiation protocol.   
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Figure 3.3: Expression of mesoderm and cardiac lineage genes in 
H3.3K56R mutant ESCs 
 
(A-D) RT-qPCR of known pluripotency (A), cardiac mesoderm (B), cardiac 
progenitor (C), and cardiomyocyte (D) marker genes in WT and H3.3K56R 
mutant ESCs differentiating from EBs. Data are normalized to WT Diff. Day 0. 
Error bars represent +/- standard deviation of three technical replicates. 
Representative data from at least two biological replicate experiments are shown. 
(E) RT-qPCR of cardiac mesoderm (blue), cardiac progenitor (purple), and 
cardiomyocyte  (red) lineage genes from the indicated timepoints during directed 
cardiomyocyte differentiation. One replicate is shown. Normalization and error 
bars are as above. 	 	
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Markers for endodermal differentiation (Figure 3.4A) and hematopoietic 
mesoderm (Figure 3.4B) were similarly affected: subsets of genes were slightly 
downregulated but not delayed in H3.3K56R mutants. Thus, it is possible that 
H3.3K56ac is only necessary to enhance the expression of certain differentiation 
markers. To further test this possibility it will be necessary to perform RNA-Seq to 
compare global gene expression during directed differentiation of WT, 
H3.3K56R, and H3.3K56Q cells. We hypothesize that H3.3K56Q mutants will be 
defective in cardiomyocyte and hematopoietic differentiation, with stabilized 
pluripotency markers similar to a Sirt6 KO (Etchegaray et al., 2015). However, it 
is also highly possible that hyperacetylation of H3.1 and H3.2 in addition to H3.3 
is necessary to observe said defects. 	
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Figure 3.4: Expression of endoderm and hematopoietic lineage genes in 
H3.3K56R mutant ESCs 
(A-B) RT-qPCR of known endoderm (A), and hematopoietic (B) marker genes in 
WT and H3.3K56R mutant ESCs differentiating from EBs. Data are normalized to 
WT Diff. Day 0. Error bars represent +/- standard deviation of three technical 
replicates. Representative data from at least two biological replicate experiments 
are shown. 		 	
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H3.3K56R mutants are defective in neuronal differentiation 
 We next tested whether H3.3K56R mutants were defective for ectodermal 
differentiation. To induce neuronal differentiation we added retinoic acid (RA) to 
EB cultures at Day 3. Addition of RA enhanced levels of ectoderm markers 
Nestin and Sox11 in both WT and H3.3K56R mutants (Figure 3.5A). As few 
neurons could be visually detected in EB cultures we attempted to enrich for 
neurons through an alternative RA induction where EBs were cultured from 
hanging drops and individually incubated with RA for 14 days (Jiang et al., 2011). 
Cultures were stained for the postmitotic neuronal marker TUJ1 (Figure 3.5B, 
top). We observed decreased numbers of TUJ1-positive cells in H3.3K56R 
cultures (Figure 3.5B, bottom), with positive cells frequently exhibiting abnormal 
axons. These data complement data from Etchegaray et al., which suggest that 
H3K56 hyperacetylation in Sirt6 KO cells pushes differentiation towards the 
ectoderm lineage (Etchegaray et al., 2015). If H3K56ac is important for ectoderm 
formation we would hypothesize that H3.3K56Q mutants would behave similarly 
to the Sirt6 KO, although it is also possible that stabilization of the pluripotency 
factors could lead to differentiation defects, particularly if the upregulated 
ectodermal differentiation observed in the Sirt6 KO is due to constitutive H3K9ac 
or acetylation of other SIRT6 targets. A third possibility, as stated previously for 
other germ layers, is that the H3K56Q phenotype can be detected only if the 
H3.1 and H3.2 variants are mutated along with H3.3. For future studies it will also 
be necessary to optimize the neuronal differentiation protocol, as fewer than 20% 
of WT cells were TUJ1-positive. It is likely that improved induction can be 
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achieved by addition of RA earlier in the timecourse (Rohwedel et al., 1999) or by 
titrating RA concentration.  
 While it will be much more informative to repeat the experiments here with 
an H3.3K56Q mutant, our data are consistent with previous work indicating that 
H3K56ac interacts with OCT4, SOX2, and NANOG to maintain ESC 
pluripotency. We also show that H3.3K56ac is important during neural 
differentiation although further ChIP-Seq or RNA-Seq studies will be necessary 
at later stages of differentiation to ascertain whether H3.3K56ac binds and 
regulates neural progenitor genes, or is indirectly required. Although ChIP-Seq 
experiments are currently limited by the lack of availability of non-crossreacting 
H3K56ac antibodies (Pal et al., 2016), it is possible that H3.3K56ac could 
regulate gene expression through H3.3 or H2A.Z. As H3K56Q yeast mutants 
have decreased H2A.Z at promoters (Watanabe et al., 2013), and H2A.Z mutant 
ESCs harbor differentiation-defective phenotypes (Creyghton et al., 2008; Hu et 
al., 2013) it is likely that H2A.Z function is compromised in H3.3K56Q mutants. 
Thus, future studies will aim to elucidate the mechanisms by which K56ac, 
pluripotency factors, and histone variants interact to regulate ESC function. 
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Figure 3.5: H3.3K56R mutant ESCs are defective in neuronal differentiation 
 
(A) RT-qPCR of ectoderm markers (left and center), and OCT4 (right) in EB 
differentiation timecourses of WT and H3.3K56R mutant ESCs. Retinoic acid 
(RA) was added at Diff. Day 3 to induce neuronal differentiation in +RA samples. 
Data are normalized to WT Diff. Day 0 and error bars represent +/- standard 
deviation of three technical replicates. Representative data from at least two 
biological replicates are shown. (B) TUJ1 (green) and DAPI (blue) staining of 
H3.3K56R and WT ESCs neuronally differentiated using the hanging drop 
method and RA (Top panel). Quantification of TUJ1-positive cells (bottom panel). 
250 cells were counted for each of two biological replicates of WT and 
H3.3K56R. Error bars represent +/- standard deviation from two biological 
replicates. 	 	
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MATERIALS AND METHODS 
Generation of H3.3K56R mutant ESC lines 
 H3.3K56R mutant ESCs were made using CRISPR/Cas9 genome editing 
 (Cong et al., 2013) as described previously (Hainer et al., 2015). Guide RNAs 
targeting K56 in H3f3a and H3f3b were cloned into pX330-puroR. K56R repair 
templates for H3f3a and H3f3b were synthesized as gblocks (Integrated DNA 
Technologies) containing ~1kb of homology and mutated PAM sites were cloned 
into pCR2.1. The cloned guide RNA and repair template vectors were transfected 
into E14 ESCs as described above. Clones were screened by TOPO cloning and 
sequencing. H3f3a and H3f3b were targeted sequentially. See Table 3.1 for 
guide RNA sequences.  
 
Cell Culture and Embryoid Body Differentiation 
E14 ESCs were maintained and EB differentiation was performed as 
described (Chapter II; (Ee et al., 2017)). 
 
RT-qPCR 
Total RNA from ESCs was prepared as described (Chapter II; (Ee et al., 
2017)). 1µg of total RNA was reverse-transcribed to cDNA using random 
hexamers (Promega). 1µl of cDNA was amplified for each RT-qPCR technical 
replicate using FAST SYBR mix (KAPA Biosystems) as described (Hainer et al., 
2015). Three technical replicates were performed per sample. GAPDH was used 
as a loading control. See Table 3.1 for primer sequences. 
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Histone Extraction and Western Blotting 
 Histones were prepared using the Gozani lab protocol: 
http://web.stanford.edu/group/gozani/cgi-bin/gozanilab/wp- 
content/uploads/2014/01/Histone-extraction-protocol.pdf. Briefly, cells were 
washed twice in cold PBS, resuspended in TEB buffer (1X PBS; 0.5% Triton X-
100; HALT protease inhibitors), lysed on ice for 10 minutes, pelleted at 2,000rpm, 
washed once in TEB, and resuspended in 0.2N HCl. Pellets were incubated 
overnight at 4°C, and supernatants collected by centrifugation.  
Whole cell lysates were prepared from EB timecourses using We16th 
buffer (25mM Tris pH 7.5; 125mM NaCl; 2.5mM EDTA; 0.05% SDS; 0.5% NP-
40; 10% w/v glycerol). The following antibodies were used for western blotting: 
anti-OCT4 (Santa Cruz sc-8628), anti-NANOG (Bethyl A300-398A), anti-β-ACTIN 
(Sigma A1978), anti-H3 (Abcam ab1791), anti-H3K56ac (Active Motif 39281). 
 
Retinoic acid and Hanging drop Neuronal Differentiation 
 For neuronal differentiation of ESCs in suspension culture, EBs were 
formed by plating in ESC media without LIF as described in Chapter II and 0.1µM 
all-trans RA (Sigma R2625) was added at Diff. Day 3. Cells were maintained in 
RA for 9 days and harvested for total RNA collection at the indicated timepoints. 
Hanging drop neuronal differentiation was performed as described (Jiang 
et al., 2011). Briefly, EBs were formed in ESC media without LIF by hanging drop 
for 2 days and transferred to 96 well Ultralow attachment plates (Corning) for 3 
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days. EBs were replated in ungelatinized 48 well plates for 11 days in ESC 
media without LIF and 0.1µM all-trans RA. 50,000 cells were replated onto 
chamber slides (Lab-Tek) overnight for TUJ1 staining. 
 
Immunofluorescence 
Cultures from neuronal differentiation in chamber slides (see above) were 
fixed with 4% paraformaldehyde and immunofluorescence performed as 
described (Chen et al., 2015) using 1:400 anti-TUJ1 (SigmaT8660) and 1:1000 
Alexa Fluor 488 rabbit anti-mouse (Life Technologies) and DAPI. Cells were 
imaged on a Nikon Eclipse E400 microscope. For quantification, 250 stained 
cells were counted each for WT and H3.3K56R. 
 
Directed Cardiomyocyte Differentiation 
 Cardiomyocyte differentiation was performed as described (Kattman et al., 
2011; Wamstad et al., 2012) with modifications. WT E14 and H3.3K56R ESCs 
were cultured for two days in serum-free media (3 parts IMDM (Cellgro 15-016-
CV); 1 part Ham’s F12 (Cellgro 10-080-CV); 0.05% BSA; 2mM L-glutamine; 
50µg/ml ascorbic acid; N2B27 supplement without vitamin A (GIBCO); 4.5 x 10-
4M monothioglycerol) to induce EB formation. EBs were dissociated with TrypLE 
(Invitrogen) and reaggregated in 5ng/ml human VEGF (PeproTech 100-20); 
8ng/ml human Activin A (PeproTech 120-14E), and 0.5ng/ml human BMP4 
(PeproTech 120-05ET) for 40 hours. EBs were dissociated again and replated in 
gelatinized 48-well plates in StemPro-34 (GIBCO 10639011); 2mM L-glutamine; 
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5ng/ml VEGF, 10ng/ml human FGF-basic (PeproTech 100-18C) and 25ng/ml 
human FGF10 (PeproTech 100-26). Beating cardiomyocytes in were first 
observed in WT cells at differentiation day 8. Cells were harvested for RT-qPCR 
at differentiation days 0, 4, and 10. 
 
Table 3.1: Oligonucleotides used in Chapter III 
Name Sequence Purpose 
H3.3a_gRNA-f [Phos]CACCGACTTTTTAGGCCTGGTACT
G 
H3.3a (H3f3a) guideRNA for knocking in K56 
mutations 
H3.3a_gRNA-r [Phos]AAACCAGTACCAGGCCTAAAAAGT
C 
H3.3a (H3f3a) guideRNA for knocking in K56 
mutations 
H3.3b_gRNA-f [Phos]CACCGTGACTGCAGGCCAGGGAC
CG 
H3.3b (H3f3b) guideRNA for knocking in K56 
mutations 
H3.3b_gRNA-r [Phos]AAACCGGTCCCTGGCCTGCAGTC
AC 
H3.3b (H3f3b) guideRNA for knocking in K56 
mutations 
H3.3aK56chk+ AGCTTTAGGCATTGCTTTCAAC PCR for checking K56 mutation knock-in in H3f3a 
H3.3aK56chk- ACTAGGCAGCCTCTACCAACAG PCR for checking K56 mutation knock-in in H3f3a 
H3.3bK56chk+ TCCCTTCTGCGTATTAGCAACT PCR for checking K56 mutation knock-in in H3f3b 
H3.3bK56chk- CCTTGAACGTCGCTTGTCTC PCR for checking K56 mutation knock-in in H3f3b 
Oct4-2 F AGAGGGAACCTCCTCTGAGC RT-qPCR primer 
Oct4-2 R TTCTAGCTCCTTCTGCAGGG RT-qPCR primer 
Nanog_RTqPCRf ATTCTTGCTTACAAGGGTCTGC RT-qPCR primer 
Nanog_RTqPCRr TTGAGAGCTTTTGTTTGGGACT RT-qPCR primer 
Brachyury-F CCAAGGACAGAGAGACGGCT RT-qPCR primer 
Brachyury-R AGTAGGCATGTTCCAAGGGC RT-qPCR primer 
Mesp1 F TTGTCCCCTCCACTCTTCAG RT-qPCR primer 
Mesp1 R AGAAACAGCATCCCAGGAAA RT-qPCR primer 
Flk1-F GCTTGCTCCTTCCTCATCTC RT-qPCR primer 
Flk1-R CCATCAGGAAGCCACAAAGC RT-qPCR primer 
Nkx2-5 F GGCTTTGTCCAGCTCCACT RT-qPCR primer 
Nkx2-5 R CATTTTACCCGGGAGCCTAC RT-qPCR primer 
Tbx5 F GGCAGTGATGACCTGGAGTT RT-qPCR primer 
Tbx5 R TGGTTGGAGGTGACTTTGTG RT-qPCR primer 
Gata4 F TGATAGAGGCCACAGGCATT RT-qPCR primer 
Gata4 R CTGGAAGACACCCCAATCTC RT-qPCR primer 
Myl7 F CTCTTCCTTGTTCACCACCC RT-qPCR primer 
Myl7 R CTCACACTCTTCGGGGAGAA RT-qPCR primer 
Tnnt2 F GTGTGCAGTCCCTGTTCAGA RT-qPCR primer 
Tnnt2 R ACCCTCAGGCTCAGGTTCA RT-qPCR primer 
FoxA2-F CCCTACGCCAACATGAACTCG RT-qPCR primer 
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FoxA2-R GTTCTGCCGGTAGAAAGGGA RT-qPCR primer 
Sox17 f CTCGGGGATGTAAAGGTGAA RT-qPCR primer 
Sox17 r GCTTCTCTGCCAAGGTCAAC RT-qPCR primer 
Gata1 F AGGGCAGAATCCACAAACTG RT-qPCR primer 
Gata1 R CCACTAAGGTGGCTGAATCC RT-qPCR primer 
PU.1 F TGCAGCTCTGTGAAGTGGTT RT-qPCR primer 
PU.1 R AGCGATGGAGAAAGCCATAG RT-qPCR primer 
Klf1 F GAGCGAACCTCCAGTCACAG RT-qPCR primer 
Klf1 R TACTCCAAGAGCTCGCACCT RT-qPCR primer 
Gypa F CCAATGTGTGGTGAGACAGG RT-qPCR primer 
Gypa R CCAAGAAGAGCATTCACCATC RT-qPCR primer 
Nfe2 F CAGGTCTCCACAAGCACAAA RT-qPCR primer 
Nfe2 R CCAGCCTCTCAGGGACACTA RT-qPCR primer 
Hba-x F GTAGGTCTTCGTCTGGGGGT RT-qPCR primer 
Hba-x R TCATCATGTCCATGTGGGAG RT-qPCR primer 
Nestin F TGGCACACCTCAAGATGTCCCTTA RT-qPCR primer 
Nestin R AAGGAAATGCAGCTTCAGCTTGGG RT-qPCR primer 
Sox11-F ACGACCTCATGTTCGACCTGAGCT RT-qPCR primer 
Sox11-R CACCAGCGACAGGGACAGGTTC RT-qPCR primer 
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CHAPTER IV: CONCLUSIONS AND DISCUSSION 
  
Nearly two decades ago, the canonical NuRD complex was isolated and 
characterized in four separate studies as a transcriptional repressor with a 
unique dual chromatin remodeling/histone deacetylase activity (Wade et al., 
1998; Tong et al., 1998; Zhang et al., 1998; Xue et al., 1998). Since this initial 
characterization, subsequent studies have largely focused on addressing three 
primary questions: 1) what is the stoichiometry of each NuRD subunit, and which 
subunits directly interact with which other subunits within the complex; 2) how is 
NuRD recruited to its genome-wide targets; and 3) how does the complex 
function at its target sites to regulate chromatin structure and gene expression? 
Additionally, further studies describe NuRD’s function with peripheral interacting 
proteins in myriad tissue, organism, developmental, and disease contexts. The 
work in this thesis provides novel insight into questions 1) and 2), and opens 
additional routes of inquiry for all three questions through the characterization of 
a largely unstudied isoform of the NuRD subunit MBD3, MBD3C. Our work 
suggests that it is necessary to consider the existence of multiple subunit 
isoforms to precisely determine the composition of NuRD and other complexes. 
Although the expression of MBD3C appears to be limited to ESCs, multiple 
isoforms or splice variants of MBD family and numerous other chromatin 
regulators are known to exist (and continue to be identified with the advent of 
advanced RNA-Seq methods). Furthermore, we have demonstrated that a single 
subunit isoform can uniquely interact with WDR5, a chromatin regulator that 
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binds histone H3, suggesting an alternative recruitment mechanism for MBD3 
beside 5hmc recognition, and for NuRD in alongside to histone binding by 
RBBP4/7 and recognition of methylated histones by the CHD3/4 
chromodomains. Further studies will be necessary to elucidate the precise role(s) 
of WDR5 within NuRD (see below). 
 
An ESC-specific MBD3 isoform and NuRD complex 
We have identified a novel NuRD complex formed through an interaction 
between the smallest MBD3 isoform MBD3C and the histone H3 binding protein 
WDR5. This form of NuRD appears to be specific to ESCs, as MBD3C 
expression is lost as ESCs differentiate, and WDR5 expression is similarly 
reduced during EB formation assays (Ang et al., 2011). WDR5 and MBD3 have 
each been shown to be required for pluripotency (Kaji et al., 2006; 2007; Yang et 
al., 2014), possibly through association with OCT4 and regulation of OCT4 target 
genes (Ang et al., 2011; Liang et al., 2008). WDR5 is also required for ESC self-
renewal (Ang et al., 2011). While WDR5 is hypothesized to be important for 
maintaining expression of pluripotent genes through H3K4 trimethlyation by the 
SET/MLL complex (Ang et al., 2011; Yang et al., 2014) our data suggest that a 
WDR5/MBD3C/NuRD complex functions separately from other WDR5 
complexes, as we did not observe other SET/MLL, MOF, or NSL subunits 
interacting with MBD3. Interestingly however, we found that MBD3C interacts 
with the WDR5 at the same binding surface as MLL1 and histone H3, using the 
same conserved arginine-containing motif (Couture et al., 2006; Patel et al., 
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2008). It is therefore also of interest to determine whether MBD3C can bind 
WDR5 only when the latter is not bound to H3/MLL1. Due to the simplicity of the 
WDR5 interaction motif, it is not unexpected that WDR5 is a member of 
numerous protein complexes. Outside of the SET/MLL protein family no amino 
acid is completely conserved within the motif apart from the alanine-arginine 
dipeptide (Figure 2.3; Patel et al., 2008). A cursory examination of the motif 
alignment in Figure 2.3 suggests a requirement for the two amino acids 5’ to the 
arginine to be relatively small (or absent, as in H3), but it is still unclear which if 
any motif amino acids are required for MBD3C to bind WDR5 aside from Arg43. 
 
A role for WDR5 within the NuRD complex? 
Although Mbd3c is expressed at lower levels than the other larger Mbd3 
isoforms and does not appear to be required on its own for ESC differentiation, 
we show that MBD3C can function redundantly with MBD3A and MBD3B to 
regulate gene expression (Figure 4.1A) with less than 40 and only ~250 genes 
misregulated in Mbd3c and Mbd3ab KO respectively, compared with nearly 
5,000 genes changed in Mbd3abc KO. Consistent with the idea that MBD3C can 
functionally compensate for the other MBD3 isoforms, a previous study found 
that while Mbd3 null ESCs exhibit loss of DNA methylation (and subsequent de-
repression of trophectoderm lineage-specific genes), the methylation phenotype 
was rescued in ESCs expressing Mbd3c alone (Latos et al., 2012). The MBD3C 
N-terminus (and therefore also the interaction with WDR5) appears to be 
important for MBD3C’s function (Figure 4.1B), as the genes changed in Mbd3abc 
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KO overlap with almost all of the genes changed in Mbd3cΔN−ab KO cells. 
Furthermore, of the 2,627 genes classified as misregulated only in Mbd3abc KO 
cells (Figure 2.9D), 837 (roughly 32%) had log2fold change values > 0.8 in the 
Mbd3cΔN−ab KO and thus were reported as unchanged due to falling just below 
the log2fold change cutoff of 1. Since Mbd3c is identical to Mbd3a and b outside 
of its N-terminus, it is not entirely unexpected that MBD3C can still regulate many 
genes when its N-terminus is deleted. While our data show that WDR5 appears 
to bind promoters of most genes changed in Mbd3abc and Mbd3cΔN−ab KO 
cells, it is likely that WDR5 regulates a large subset of these genes through 
mechanisms independent of Mbd3c/NuRD, as it has been shown that WDR5 
also functions as a member of the MOF acetyltransferase complex independently 
of MLL H3K4 methlyase activity (Dias et al., 2014; Li et al., 2012). Further studies 
will be necessary to determine the genomic regions specifically targeted by 
MBD3C and WDR5, as well as pinpoint unique functions of the individual MBD3 
and WDR5 complexes. For all such studies it would be important to be able to 
distinguish the effects of Wdr5 KD on MBD3/NuRD from the phenotypes caused 
by the loss of WDR5 function in SET/MLL or MOF complexes. It is moreover 
important to note that there are alternative models to the sequestration model 
proposed in Figure 4.1. Rather than acting as a molecular sponge that prevents 
WDR5 from associating with activating complexes, MBD3C/NuRD could be 
recruiting WDR5 to fine-tune the expression of NuRD target genes (by 
counteracting HDAC- or CHD-mediated repression) or using WDR5 as an 
additional histone-binding module. As WDR5 is known to interact with a large 
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subset of lncRNAs in ESCs using a binding surface opposite to that of MBD3C 
and H3K4 (Yang et al., 2014) it would be interesting to test whether any of these 
lncRNAs also bind and/or recruit MBD3C/NuRD.  
Much has been made of MBD3’s function as a transcriptional co-
repressor; however, in agreement with transcriptome analyses from previous 
studies (Günther et al., 2013; Hainer et al., 2016; Luo et al., 2015) our RNA-Seq 
analysis indicates that MBD3 can also function as an activator, with several 
thousand genes downregulated in Mbd3abc KO ESCs. Likewise, this work is the 
first known example of WDR5 functioning as part of a repressive complex.  
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Figure 4.1: MBD3C is a redundant regulator of gene expression in ESCs 
(A) MBD3C binds WDR5 via a conserved N-terminal motif (dark blue).  
MBD3C/NuRD is redundant in gene regulation with MBD3A/NuRD and 
MBD3B/NuRD. (B) Interaction with WDR5 is required for gene regulation by 
MBD3C. Pluripotency genes are derepressed if all MBD3/NuRD activity is lost. A 
possible scenario is that further upregulation of genes may occur through 
increased association of WDR5 with transcriptional activators. See text for more 
details. 
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Significance of the methyl-CpG binding domain 
 DNA methylation is an epigenetic modification common to vertebrates and 
conserved in numerous invertebrate, plant, and fungal species. Methylated 
genes are commonly silenced, and the question of how this repression occurs 
continues to be a focus of the methylation field today. While the most 
straightforward mechanism is that DNA methylation physically blocks or renders 
chromatin at gene promoters inaccessible to the transcriptional machinery, the 
presence of the MBD family proteins in organisms exhibiting DNA methylation 
implies that methylation could provide binding sites or signals for repressive 
chromatin remodelers, with the MBD proteins as “readers” of the methylation 
mark. Mammalian MBD3 contains substitutions of His30 and Phe34 for lysine 
and tyrosine in the MBD, resulting in the loss of the ability to bind 5mc. Although 
the relative affinity of MBD3 for 5hmc is still disputed in the field (Cramer et al., 
2014; Hashimoto et al., 2012; Mellén et al., 2012; Spruijt et al., 2013; Yildirim et 
al., 2011)) our lab’s finding that TET1 catalytic activity is required for MBD3 
localization in ESCs (Hainer et al., 2016; Yildirim et al., 2011) suggests that the 
MBD3 MBD has further evolved to recognize and recruit the NuRD complex to 
genomic regions undergoing demethylation.  
The question of the MBD’s biological significance was first raised soon 
after the initial characterization of the MBD proteins. DNA methylation is essential 
during embryonic development (Li et al., 1992; Okano et al., 1999), but of the 
MBD proteins only MBD3 appears to also be necessary. As the MBD3 MBD does 
not bind 5mc, it was postulated that the MBD could be unimportant for either 
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development or for transcriptional repression. Our observation that MBD3C 
(which completely lacks the MBD), can functionally compensate for MBD3A and 
B in the regulation of gene expression in ESCs seems to cast further doubt on 
whether the MBD is actually essential for NuRD complex function and/or 
methylation-induced gene repression. It is noteworthy that the MBD3B isoform 
lacks almost the entire MBD but can also rescue wildtype levels of gene 
expression, proliferation, and methylation when expressed in Mbd3 null ESCs 
(Kaji et al., 2006; Latos et al., 2012). We have further found that constitutive 
Mbd3cΔN overexpression in Mbd3abc KO ESCs allows for normal kinetics of 
OCT4 and NANOG loss during differentiation (Figure 2.7A). Taken together, 
these data point to a greater role for the MBD3 C-terminal region in ESC 
pluripotency and differentiation, and suggests a diminished importance for the 
MBD. Further studies would be necessary to elucidate significant functional 
domains within the C-terminal region. The three MBD3 isoforms are identical in 
sequence from exon 3 to the stop codon, which creates some functional 
redundancy and underscores the importance of the C-terminus. As MBD3/NuRD 
is required for ESC differentiation and embryonic viability it therefore seems likely 
that ESCs express all of the isoforms as a means to ensure proper development 
as much as possible, with WDR5 allowing for MBD3C to function in gene 
regulation as an additional backup mechanism in the absence of MBD3A and B.   
Interestingly, although Mbd3 and Mbd2 null mice have very different 
phenotypes (Hendrich et al., 2001) the genome-wide localization of MBD3 and 
MBD2 is highly interdependent and also dependent on DNMT1 and TET1 (and 
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thus also on 5mc and 5hmc) in ESCs (Hainer et al., 2016). Therefore, the 
importance of the MBD as a NuRD recruitment module cannot be entirely 
dismissed, as MBD3 may require recognition of methylated DNA by MBD2’s 
MBD to bind to a subset of targets. Furthermore, 5mc and 5hmc levels are 
decreased in both Mbd3 and Mbd2 KD cells, resulting in a regulatory loop of 
gene expression (Hainer et al., 2016) and consistent with previous studies 
showing that 5mc and 5hmc are dependent on MBD3 (Latos et al., 2012; Yildirim 
et al., 2011). Although our lab has shown that MBD3 and TET1 physically 
interact (Yildirim et al., 2011), the MBD3 isoforms that bind TET1 or 5hmc and 
the mechanism of 5mc and 5hmc regulation by MBD proteins are still unknown. It 
is therefore possible that the MBD is required for DNMT and/or TET1 function. 
 
Why MBD3C? 
 Although MBD family proteins are typically found in organisms where DNA 
methylation is also present, MBD3C is not highly conserved. A protein BLAST 
search of the 50-amino acid N-terminal domain revealed significant similar 
sequences only among rodent species. Strikingly, amino acids 21-50 appear to 
be the most highly conserved, hinting at an important role for the WDR5-
interacting motif in rodent development (Figure 4.2). In contrast, homology to the 
first 20 amino acids in MBD3C was detected only in two species of rat, Rattus 
norvegicus and Neotoma lepida. Thus, the evolutionary question remains 
unanswered: what necessitated the MBD3C isoform in rodents, or why has the 
isoform been lost in other species? As MBD3 is required for embryonic 
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development and MBD3C is largely functionally redundant with MBD3A and B in 
ESCs, MBD3C could have arisen simply as a backup for the other isoforms in 
case expression from the MBD3A/B start site was somehow lost. Since MBD3C 
is subsequently lost during differentiation, it is likely that MBD3 function becomes 
absolutely critical in the blastocyst before and in the early stages of lineage 
commitment. Mouse development during implantation differs slightly from that of 
humans, particularly in the formation of extraembryonic tissues from the 
trophectoderm. In the mouse the trophectoderm requires FGF4 to proliferate into 
extraembryonic tissues; in humans this proliferation occurs later in development 
and does not rely on FGF signaling (reviewed in (Rossant, 2015)). Although the 
expression patterns of individual MBD3 isoforms during embryogenesis have not 
yet been described, it is possible that MBD3C is also critical at this stage for, or 
oppositely to counterbalance, FGF signaling as Mbd3 null ESCs have been 
shown to upregulate expression of trophectoderm markers (Kaji et al., 2006; Zhu 
et al., 2009). 
 A second difference between mouse and human ESCs is utilization of the 
threonine dehydrogenase (TDH) catabolism pathway. While threonine is required 
for growth and is catabolized by all mammalian cells as an essential amino acid, 
the Tdh gene has been shown to be inactive in humans (Edgar, 2002), while 
TDH enzyme is very highly expressed and active in undifferentiated mouse ESCs 
(Wang et al., 2009a), entailing the hypothesis that the TDH pathway facilitates 
the fast proliferation rate of mouse ESCs that is not observed in humans. 
Although we do not observe a proliferation defect in Mbd3c KO ESCs (Figure 
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2.6B), it is possible that MBD3C could also function redundantly with MBD3A and 
B, and evolved as a backup for the other isoforms in the regulation of the TDH 
pathway. ESCs expressing only MBD3C (Mbd3ab KO) do grow more slowly than 
WT, but the proliferation defect is not as severe (Figure 2.6C), and our mass 
spec analysis detected small numbers of TDH peptides in all MBD3 purifications 
(Tables 2.1 and 2.2). While it is unlikely that MBD3 directly regulates TDH as 
most TDH enzyme is situated in the mitochondria, it is possible that MBD3 is 
important for expression of the Tdh gene. Consistent with this idea, Tdh 
expression is significantly decreased in Mbd3abc, Mbd3ab, and Mbd3cΔN−ab 
KO cell lines (log2fold change of -1.84, -0.57, and -1.17 respectively from our 
RNA-Seq data). Although MBD3C is not present in many species with a 
functional Tdh gene, it would be of interest to determine whether ESCs from 
these species utilize the TDH pathway to enhance proliferation, and whether 
MBD3 is also involved. 
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Figure 4.2: Protein BLAST alignment of the MBD3C N-terminus with rodent 
MBD3 isoforms 
Protein BLAST alignment of the mouse 50-amino acid MBD3C N-terminus with 
MBD3 isoforms from other rodent species is shown. Differing amino acids are 
depicted in red; the alanine-arginine motif required for WDR5 interaction (Figure 
2.3; Patel et al., 2008) is shown in green. 
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Further insight into the functions of H3K56ac in pluripotency and 
differentiation 
 While our data in Chapter III are largely preliminary and experiments are 
ongoing, several conclusions can still be drawn. We have shown using 
acetylation-depleted H3.3K56R mutants that H3.3K56ac is dispensable for ESC 
self-renewal, but not for differentiation, as we observe that expression of some 
germ layer markers is decreased and H3.3K56R mutants are defective in 
neuronal development. The effects of H3.3K56ac on pluripotency appear to be 
somewhat context-dependent, as some cardiac lineage genes downregulated in 
EB differentiation are expressed normally during directed differentiation with 
defined growth factors and serum-free culture conditions. Our data showing that 
ESCs depleted for H3.3K56ac are defective in differentiating into the ectoderm 
lineage and in forming neurons are consistent with previous data in Sirt6 KO 
cells. H3K56 is hyperacetylated in the Sirt6 KO and these cells are skewed 
during differentiation towards the ectoderm lineage (Etchegaray et al., 2015). We 
anticipate that we will observe a similar phenotype upon repeating differentiation 
assays using the acetylation mimic (H3.3K56Q) ESC lines, in addition to failure 
to downregulate pluripotency factors and decreased expression of mesoderm 
and endoderm markers. However, as briefly discussed in Chapter III SIRT6 
targets other histone residues including H3K9 and H3K18 (Michishita et al., 
2008; Tasselli et al., 2016)), and it is possible that the phenotypes observed by 
Etchegaray et al. result from pan-H3 hyperacetylation. Taken together, the 
current evidence points toward a role for H3K56ac in maintaining ESC 
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pluripotency in conjunction with the “master” regulators such as OCT4, with 
deacetylation of H3K56 necessary to exit the pluripotent state. Consistent with a 
shift in H3K56ac localization to developmental genes during differentiation of 
human ESCs (Xie et al., 2009) our data suggest that H3.3K56ac likely enhances 
but is not absolutely required for expression of some mesodermal and 
endodermal lineage markers during development. Interestingly, we did not 
observe mis-expression of two common ectoderm markers, Nestin and Sox11 
during RA-induced EB differentiation despite a clear defect in the formation of 
TUJ1-positive neurons using a directed differentiation protocol (Jiang et al., 
2011) although it is likely Nestin and Sox11 are downregulated in the directed 
differentiation). Optimization of our neuronal differentiation timecourse protocols 
and ChIP- and RNA-Seq analysis will be necessary to determine if a similar shift 
in H3K56ac localization occurs in mouse ESCs and which neuronal genes are 
affected by depletion of H3.3K56ac. 
 It is of particular importance to determine which phenotypes result 
specifically from deacetylation or hyperacetylation of H3.3 versus the core 
histone variants. Although targeting every endogenous copy of H3.1/2 using 
CRISPR is technically difficult, and knockdown of the H3K56ac acetyltransferase 
p300 would impact multiple acetylated sites, hyperacetylation of H3.1/2 could be 
studied using overexpression vectors. It is also currently unknown whether H3.3 
or H3.3/H2A.Z-containing nucleosomes are enriched for K56ac. Assuming that 
suitable antibodies against H3K56ac can be synthesized, it would be interesting 
to perform ChIP-Seq of H3.3, H2A.Z and H3K56ac in parallel to test whether they 
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are enriched at the same genomic regions, and in H3.3K56R and H3.3K56Q 
mutants to determine whether localization patterns are interdependent and/or 
correlate with gene expression. Because the H3K56Q mutant allows the yeast 
SWR-C complex to promiscuously exchange H2A.Z and H2A dimers (Watanabe 
et al., 2013), it is possible that examining INO80 complex function in the K56R 
and K56Q mutants will provide more insight into H3K56ac- and H2A.Z-mediated 
gene regulation in ESCs and other mammalian cells. In their characterization of 
the Sirt6 KO, Etchegaray et al. describe another possible mechanism for 
H3K56ac function. They were able to rescue the Sirt6 KO differentiation 
phenotypes by knocking down the Tet1 or Tet2 genes, which are target genes of 
OCT4 and SOX2 (Koh et al., 2011; Wu et al., 2013) and function in oxidation of 
5mc to 5hmc (Ito et al., 2010; Tahiliani et al., 2009). In the Sirt6 KO, increased 
5hmc as well as the activation-associated histone mark H3K4me2 were observed 
at ectodermal genes (Etchegaray et al., 2015), leading to a model where H3K56 
deacetylation by SIRT6 during differentiation represses OCT4 and SOX2, which 
then prevents excessive TET-mediated demethylation and activation of 
ectodermal genes. The Tet1/2 KD rescue phenotype is observed both in cell 
lines and in teratomas from Sirt6 KO ESCs. While this model does not entirely 
explain why other lineage genes are downregulated in H3K56 hyperacetylation 
mutants, further examination of DNA methylation and TET enzyme function in 
H3.3 and H3.3K56 mutants would be informative, particularly as Tet1 KD, like 
H3.3 depletion allows ESCs to upregulate trophectodermal markers 
(Banaszynski et al., 2013; Koh et al., 2011). In conclusion, our work corroborates 
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previous studies showing that H3K56ac is important for maintaining pluripotency. 
Further studies are necessary to elucidate how H3K56ac affects lineage genes 
during differentiation, and how H3K56ac functions alongside the other H3 
variants, INO80 and H2A.Z, and regulators of DNA methylation at different 
developmental stages.
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